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 Health systems' strengthening is essential in South Africa in an era of the convergence of 
communicable and non-communicable diseases. Whilst TB is ranked first in all-cause 
mortality, non-communicable diseases which include cerebrovascular disease and 
diabetes mellitus follow; with HIV/AIDS in fourth place. In the Western Cape, diabetes 
mellitus and HIV are the top two causes of death accounting for 6.8% and 5.8% 
respectively (StatsSA, 2015b). As the burden of non-communicable disease continues to 
increase significantly due to more South Africans presenting these co-morbid conditions, 
the complexity of managing these chronic conditions has increased. The reorganisation of 
primary health services to better cater for patients with multiple chronic conditions has 
become an imperative in South Africa but still in its infancy. However, how chronic 
patients with multi-morbidities experience the current services and what their perceived 
needs are in order to enhance the management of their conditions both at point of 
healthcare and in their daily lives is not widely understood.  
 
Below, is an outline of the three parts presented in this dissertation. Part A is the study 
protocol, which gives a background of the intersection of communicable and non-
communicable diseases in South Africa, focusing on HIV and type two diabetes 
(hereafter HIV/T2D) co-morbidity. A qualitative design was employed. In-depth 
interviews were conducted with ten patients living with HIV/T2D co-morbidity and six 
health workers who interacted with these patients. Ethical considerations such as 
potential risks and benefits; confidentiality, autonomy and informed consent are also 




Part B is the structured literature review on chronic care in low and middle-income 
countries (LMICs). Two sub-sections are presented with the first focusing on LMICs 
excluding South Africa; and the second for South Africa only. Theoretical frameworks, 
which were applied to managing chronic conditions and empirical studies on HIV/T2D in 
these LMICs, are reviewed. Reference to the Cumulative Complexity Model (CCM), will 
also provide an in-depth understanding of the prospects of strengthening the primary 
healthcare system in South Africa to address chronic conditions more effectively.  
 
Part C is the journal-ready manuscript of the data collected in the qualitative study. It 
consists of the background, methods, results, discussion and conclusions. Findings 
describe patients’ experiences of the primary healthcare services and the daily challenges 
of living with and managing HIV and T2D among a sample of ten patients attending a 
clinic in Cape Town. Health worker perspectives on managing HIV/T2D co-morbidity 
are also presented. Both patients and healthworkers also shared strategies on how health 
interventions could be more responsive to HIV/T2D co-morbidity. Hence, further 
contributions are made in the knowledge base of strengthening chronic conditions. 
However, further research with different subsets of patients living with not only 
HIV/T2D but also other co-morbid or multi-morbid conditions is important for 
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Health systems are made up of the global and national contexts (macro); local health 
system contexts (meso level); and the individual context (micro level). Interaction with 
the citizens is reiterated across the three levels such as provision of health services that 
are responsive to the needs of the local health system context (Gilson, 2012) and 
inclusion of citizens in policy planning (Green, 2007).  Most low and middle-income 
countries (LMICs) are experiencing the convergence of non-communicable diseases 
(NCDs) and communicable diseases (CDs) especially due to decreased mortality and the 
ageing of the HIV infected (Rabkin et al., 2012, Remais et al., 2013).  
 
The South African health system consists of the public and private sectors and is largely 
inequitable due to the racial, gender, socio-economic and socio-political factors dating 
back from the apartheid era (Coovadia et al., 2009, McIntyre et al., 2007). The public 
sector is State-run where in each of the nine provinces; there is free primary healthcare at 
primary health centre (PHC) level and a referral system for curative services from the 
PHC to the district, regional and tertiary hospitals (Coovadia et al., 2009). 30% of the 
doctors in the country provide services to more than 84% of the population who are 
public patients. The private sector consists of for-profit general hospitals and private 
specialists. Private sector patients are approximately 16% of the population; with 
approximately 75% of private patients affiliated to medical aid schemes. Approximately 
25% of private patients paying out-of-pocket (Mayosi et al., 2009) are dependent on the 




While the epidemiological transition of the convergence of NCDs and CDs has been 
acknowledged in the South African  public health facilities through strategic plans at 
national level (DoH, 2013) the implementation is less forthcoming towards public sector 
patients. Interventions are often designed to improve health and evaluated against local or 
national health system goals, but patients' experiences in managing these chronic 
conditions on a daily basis is often overlooked. This is evident in the challenges of large 
chronic programmes where patient outcomes may become sub-optimal (Cornell et al., 
2010).   
 
The proposed study intends to investigate patient workload and capacity for managing 
HIV and type 2 diabetes (hereafter HIV/T2D) co-morbidity in the Western Cape 
Province, South Africa.  The objective is to explore the patient and health provider 
perspectives related to workload, which accompanies co-morbidity and how this affects 
the patient’s capacity to manage these conditions effectively. This will provide fresh 
insights into how health systems may be strengthened for chronic care. For this study, 
HIV/T2D co-morbidity is the selected co-morbid condition due to the increasing T2D 
prevalence in sub-Saharan Africa (SSA)  (Levitt et al., 2011, Oni et al., 2015) as well as 
the heavy workload needed for optimal T2D (Haque et al., 2005) and HIV management. 
Shippee's Cumulative Complexity Model (CCM) (Shippee et al., 2012) will be used to 
guide the investigation. This is a patient-centred framework that emphasises that the 
imbalance where workload exceeds capacity is the primary driver of disruptions in care, 
self-care, and outcomes. The model also incorporates treatment and illness burden. There 
has been no other research in South Africa to date that has investigated this issue. 
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Background 
Epidemiology of HIV and T2D 
HIV is classified as an infectious disease where the cells of the immune system are 
impaired of their functioning or destroyed. This results in various opportunistic infections 
and there is high risk of advanced to severe symptoms as it progresses to AIDS (WHO, 
2015). Though the condition is managed through antiretroviral therapy (ART); non-
adherence to treatment and the high prevalence rate have also contributed to the high 
burden of the disease on the health system in LMICs (Bangsberg et al., 2001, Nachega et 
al., 2010). The burden of HIV on the health system is further compounded by 
presentation of one or more chronic diseases, such as cardiovascular disease (Vance et 
al., 2011), hypertension (Maduagwu et al., 2012) TB and type 2 diabetes (Faurholt-
Jepsen et al., 2012). Particularly, women who are receiving ART such as stavudine are at 
risk of acquiring T2D as the body composition can be altered  to having central fat 
accumulation and peripheral fat wasting (Dave et al., 2011) and other NCDs especially as 
they grow older (Rabkin et al., 2012). 
On the other hand, Type 2 diabetes (T2D) consists of metabolic diseases which result 
from defects in insulin secretion, insulin action, or both because of raised glucose levels 
in the blood (hyperglycemia) (American Diabetes Association, 2010) which makes it the 
most difficult NCD to manage (Kerr et al., 2007). The complexity of treating T2D is 
unique to each patient and is further aggravated by the severity of the metabolic 
abnormality which can progress, regress, or stay the same (American Diabetes 
Association, 2010) leading to a  wide array of health complications. These range from 
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metabolic abnormalities such as chronic kidney disease (Kalra and Agrawal, 2013) and 
impaired cognitive functioning (Vance et al., 2011). 
 
The prevalence and incidence rates of HIV/T2D co-morbidity are not published 
aggregate. Globally, there were approximately 35 million people living with HIV; with 
24.7 million coming from SSA (WHO, 2014b).  Global estimates for the prevalence of 
diabetes (both Type 1 and Type 2) was 9% in 2014 (WHO, 2014a); with a global increase 
specifically for type 2 diabetes (Aguiree et al., 2013); (Hall et al., 2011). HIV continues 
to be ranked as the leading cause of mortality (WHO, 2014b) and diabetes is projected to 
be the 7th  leading cause of death by 2030 (Wild et al., 2004). 
 
In South Africa,the incidence rate of HIV has dropped from 12.2% in 2012 (Shisana and 
Onoya, 2014) to 11.2% in 2015 (StatsSA, 2015a) . However, HIV is still ranked fourth in 
all-cause mortality, accounting for 4.8% of deaths in 2014 after TB (8.4%), 
cerebrovascular disease (5.1%) and diabetes mellitus (5.0%). In the Western Cape, 
diabetes mellitus and HIV are the top two causes of death accounting for 6.8% and 5.8% 
respectively (StatsSA, 2015b). A cross sectional study in the Western Cape Province on 
multi-morbidity (HIV, TB, T2D and hypertension) showed the highest prevalence of 
multi- morbidity in the 36-45 and 46-55 age group; with T2D patients and HIV patients 
both having hypertension as the major co-morbid condition (Oni et al., 2015). 
Interventions to manage co-morbidity of HIV and T2D  
 
The myriad of interactions between HIV and T2D (Oni and Unwin, 2015) as a co-morbid 
condition reinforce the idea that health systems strengthening must come first (WHO, 
18 
2007) to "prevent mortality and morbidity and improve patient outcome" (Kalra and 
Agrawal, 2013). The Innovative Care for Chronic Conditions (ICCC) model developed 
by the World Health Organisation (WHO) recommends a systems approach to chronic 
care where a patient is seen to be in an environment that is made up of family, 
community, health providers and policy makers. It is these systems that have to support 
the patient in managing the chronic conditions (WHO, 2002). 
In other developed regions such as Australia, HIV care programs have been adapted to 
include the screening for multi- morbid chronic conditions (Foster et al., 2011). Progress 
has also been made in Latin America where governments are not only focusing on HIV 
care programs, but also working towards the establishment of the infrastructure necessary 
for NCD prevention and management (Crabtree-Ramirez et al., 2014). However, in low-
resource settings of SSA, the adaptation of HIV programs for the management of other 
chronic conditions such as T2D have only been suggested and integration has not yet 
taken place widely (Rabkin et al., 2012); with the exception of a few regions (Pastakia et 
al., 2013, Aantjes et al., 2014, Wroe et al., 2015).  Though there is improved availability 
of HIV care in SSA, there is an absence of horizontal care services for NCDs, which 
gives rise to preventable, premature morbidity and death (Narayan et al., 2014). 
 In South Africa, improved chronic care is a priority objective of the Department of 
Health (DoH) in the provision of healthcare services (DoH, 2013). In this regard, the 
adaptation of the ICCC model is embodied in the three National Strategic Plans (NSPs) 
formulated by the state's Department of Health: the NSP on HIV, STIs and TB 2007-
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2011; NSP on HIV, STIs and TB 2012-2016; and the NSP for the Prevention and Control 
of NCDs 2013-2017. 
 
The NSP on HIV, STIs and TB 2007-2011 prioritised scaling up of HIV treatment as 
many people were dying due to lack of universal coverage of anti-retroviral treatment 
(ART) (DoH, 2006). In addition, the NSP on HIV, STIs and TB 2012-2016 aims to 
reduce the HIV incidence rate through HIV prevention programmes such as medical male 
circumcision (MMC) and free condom distribution in all public facilities (DoH, 2011). 
Although  the scale-up of ART consequently led to increasing prevalence of HIV in 
ageing populations (Rabkin et al., 2012), the two aforementioned NSPs are noteworthy 
for prolonging of life and reducing mortality. 
 
The NSP for the Prevention and Control of NCDs 2013-2017 aims to strengthen the 
health system response to NCDs, TB and HIV due to their convergence with other NCDs; 
which was not the case with the previous NSPs. It also adopts a novel framework, the 
Integrated Chronic Disease Management (ICDM) model that is modification of the ICCC 
framework to the South African context. The three strategic objectives of the ICDM are 
to create a positive policy environment for managing chronic conditions, enhancing and 
mobilising community resources for chronic conditions and to re-orientate the health 
service delivery for improved chronic patient outcomes (DoH, 2013); which 
acknowledge the new wave of multi-morbidity in the South African population. Hence, 
the weakness of the ICCC model which does not account for multi morbidity (Oni et al., 
2014) is addressed by the ICDM. 
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However, in the ICCC, ICDM and national programs presented above; patients' workload 
and capacity issues to deal with their co-morbid conditions is not addressed as a 
consideration.  An examination of the feasibility of effectively managing co-morbid 
conditions can be done using the Cumulative Complexity Model (CCM.) The CCM 
posits that as the burden of disease and resulting workload increases, the patient capacity 
to respond to it diminishes. ‘Patient workload’ is defined as the patient's daily tasks and 
responsibilities such as self-monitoring, self-care, treatment/medicines management and 
clinic visits expected by healthcare providers. ‘Patient capacity’ includes the patient’s 
abilities, personal and social resources that they can bring to bear to meet these 
expectations, for instance physical and mental functioning, socioeconomic resources, 
social support, literacy, and attitudes/ beliefs. The extent of the burden and its effects on 
capacity can negatively affect both health care and health outcomes, generating a spiral of 
deterioration (Shippee et al., 2012).  
Research question 
 
What are the experiences and perspectives of public sector patients in Cape Town in 
managing the workload and demands of multi morbidity (HIV and T2D) and how does 
this impact on their capacity for effective self-management?    
Primary objectives: 
 To identify and describe workload/capacity issues and their inter-relationships as 
associated with multiple morbidities from the patient perspective   
 To identify the health worker and middle health managers perspectives on patient 




 Secondary objectives: 
 How are demands of treatment, self-care and life in general experienced and 
prioritised by the patients?  
 How do health workers delegate work to patients with HIV and T2D?  
 What resources do the patients have which enable performing the delegated 
work? 
 How are poor patient outcomes diagnosed and addressed?  
 What programmes are in place to encourage balance between treatment demands 
and wellbeing of patients with HIV and T2D?  
 What platforms exist in which patients can contribute to a positive health care 
experience and are patients aware of them?  
Study setting 
 
The study will be conducted at Site B Ubuntu ART clinic (Site B) in Khayelitsha, Cape 
Town.  Ubuntu is the longest standing site in Western Cape to provide ART in the public 
health sector (Médecins Sans Frontières, 2010) and is thus well established. A study 
conducted in a similar setting in Khayelitsha reported that 19% of ART patients visiting 
the clinic have more than one morbidity; among them hypertension, diabetes and TB (Oni 
et al., 2015). One site will be used as this is a pilot project testing the feasibility of 








A qualitative study design will be used to explore how patients with HIV and T2D 
manage the workload and capacity issues inherent in chronic conditions and the role 
played by health workers in ensuring patients achieve effective self-management. 
Qualitative research is intended to approach the world “out there” and to understand, 
describe and sometimes explain social phenomena “from the inside perspective” (Flick, 
2013). The implication is that qualitative researchers focus on the meaning research 
participants attach to their day-to-day experiences and aim to understand the participants' 
context (Taylor et al., 2015). 
 
Data collection methods will be in-depth, one-on-one semi structured responsive 
interviews with patients and health providers. Semi-structured questionnaires allow 
flexibility in data collection such as re-formulating questions if the participant does not 
understand, or encouraging the participant to expand on a particular response through 
using follow-up questions (Bryman, 2012). Responsive interviewing is defined as the use 
of main questions, probes and follow up questions; and it promotes partnership between 
the participant and the researcher throughout the research process as the participant is not 
treated as an object of research (Rubin and Rubin, 2011).  Individual interviews have also 
been chosen as the preferred method because discussion of lived experiences of 
managing chronic conditions with patients may be very personal and patients may prefer 
confidentiality; and due to their varied work commitments and time constraints focus 
group discussions cannot be done with health workers.  
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In-depth interviews with patients 
 
Ten (10) semi-structured interviews will be done to elicit the personal experiences, 
perspectives, attitudes and opinions of patients in managing their HIV/T2D co-morbid 
condition. A semi-structured questionnaire for patients will be drafted in English and 
used to guide the interview process. As Xhosa, Afrikaans and English are the main 
languages spoken in Western Cape, with Xhosa being the dominant language in 
Khayelitsha, a Xhosa speaking translator will accompany the researcher in conducting the 
interviews. This will allow the translator to assist in the interviewing if the participant 
cannot fully articulate or comprehend English in some parts of the interview. It is 
anticipated that each interview will last for an hour or more. The interviews will be audio 
taped and transcribed later for analysis. Data collection and analysis will be done over six 
months. This is because there is a high patient turnover at Site B, which will allow data to 
be collected over a month, and the remaining five months will be reserved for analysis.  
In-depth interviews with health providers 
 
Six (6) semi-structured in depth interviews, guided by a semi-structured questionnaire for 
health workers will also be done with health workers working at Site B who provide care 
for patients with HIV/T2D co-morbidity. These include doctors, nurses, and lay 
counsellors. These health workers have frequent contact with the patients and they will 
give their perspectives on the burden of care for patients with multi-morbidities, the 
challenges experienced by the patients and health providers, what tasks they assign to the 
patients and how they try to assist in developing patient capacity. Additionally, they will 
provide insight on the existing policies that influence them and the patients in managing 
HIV/T2D co-morbidity.  
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Characteristics of study population  
Sample selection and size  
 
As this is a sub-study of an ongoing study that is screening diabetic patients for TB and 
HIV (Ethics reference number: HREC Ref: 403/2011), HIV/T2D co-morbid patients will 
therefore be identified from the parent study and approached for consent (see research 
procedures and data collection methods below). An equal distribution of both sexes for 
patients (5 men and 5 women) with T2D/ HIV co-morbidity is anticipated; and six health 
workers working with chronic patients will be interviewed. In the patients group, the 
inclusion and exclusion criteria will be cross-checked with the patient files and are as 
follows:  
Inclusion criteria 
 Chronic patients who have both HIV and T2D 
 Registered at Ubuntu as part of ongoing study  
 Initiated ART and also on treatment for T2D 
 Both male and females in the 35 - 65 years category 
 Capable and willing to provide informed consent  
 Capable and willing to be interviewed in simple English 
Exclusion criteria 
 Chronic patients who do not HIV and T2D as some of their co-morbidities 
  Not registered at Site B  
 Below 35 years as this has a higher chance of being type 1 diabetes 
 Above 65 years (as it is the least affected age group in this setting) 
 A known history of mental illness  
25 
 Clinically diagnosed depression
In the health workers group, the inclusion and exclusion criteria will be as follows: 
Inclusion criteria 
 Health managers
 Health workers who work with adult chronic patients
 Capable and willing to communicate in simple English
 Capable and willing to provide informed consent
Exclusion criteria 
 Health workers who do not work with adult chronic disease patients
Recruitment and Enrollment 
The total number of participants to be enrolled for the study is 10 patients and 6 health 
workers (N=16) as this is a pilot project/ sub-study from an ongoing study with a limited 
budget. To recruit patients, the researcher will liaise with the research medical officer 
running the parent study to facilitate identification of eligible patients. The researcher 
will place a note in the patient's file if they meet the eligibility criteria, so that when the 
patient is consulting with the doctor or the pharmacy, the patient can be referred to the 
researcher after consultation. The researcher will then explain the study to the potential 
participant who is free to decline or be part of the study. 
To recruit health workers, the researcher will make initial contact with the Site B facility 
manager who will assist in identifying staff members to be interviewed who fit with the 
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inclusion and exclusion criteria for health workers. The potential health worker 
participants will include both allied health workers and clinicians. The researcher will 
informally approach the identified individual health workers whenever they are free until 
a total of 6 has been reached.  
 
Convenience sampling will be used for both patient and health worker participants 
because the researcher will rely on available participants (Babbie, 2010, Ritchie et al., 
2013) at the clinic. Purposive sampling will also be done as the researcher will also draw 
participants from this population based on the eligibility criteria. Patients have the 
knowledge on the workload and capacity which come with HIV/T2D morbidity. Health 
workers have the ability to provide much needed information on the assigning of tasks to 
patients with HIV/T2D co-morbidity.  
Research Procedures and Data Collection Methods  
 
In-depth interviews will be conducted by the researcher with each research participant 
(both patients and health workers) in order to gain more insight on how HIV/T2D and 
HIV co-morbidity is managed. In this regard, each interview will be face to face and held 
in confidence in a private room (Ritchie et al., 2013). This will create a conducive 
atmosphere for the participant to speak freely and openly about sensitive issues. The 
researcher will explain the purpose of the study to the participant first, and then obtain 
both verbal and written consent (Appendices 1 and 2). Interviews will be audio taped and 
each interview will last for an hour; aided by two separate interview guides.  
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The interview guide for patients will include questions on: demographic data, workload 
(the demands on patients time and energy, the demands of treatment, self-care, other co-
morbidities, access to care for HIV and T2D treatment and family responsibilities) and  
capacity to cope with the workload (financial and social resources, health literacy and 
morbidity as it affects ability to function) (Appendix 3). For the health workers, the 
interview guide  will include questions on: how tasks are assigned to patients with multi-
morbidity (how often should patients come for follow ups, how often should medication 
be taken, number of medicines, how many health workers should the patient see), how 
poor patient outcomes are diagnosed and addressed, programmes in place to maintain the 
balance between treatment demands and mental well being/social functioning (such as 
support groups, counselling service, food gardens), and the possibilities on how to change 
the decision making processes between the patient and health worker  to ease patient 
workload and improve health outcomes (Appendix 4). 
 
Refreshments will be given during the course of the interview to both patient and 
provider participants. Interviews' transcriptions will be done verbatim and in English. A 
Xhosa translator will accompany the researcher to every interview and will be of service 
when the research participant needs clarity in the vernacular. This translator works for the 
Chronic Disease Institute of Africa (CDIA) and is fully proficient in both Xhosa and 
English. At the end of the interview, a food voucher to the value of R100 will be given to 
patient participants only, which will be redeemable at a local store (Shoprite). They will 
be encouraged to use it for healthy food.  
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The researcher has sound experience in conducting qualitative interviews as she is a 
social worker experienced in psychosocial counselling. The researcher has also 
previously done qualitative research at an undergraduate and honours levels; and has also 
done courses on qualitative research methods and qualitative data analysis at Master's 
level. Further training was also done in a one-day workshop with the qualitative research 
experts who conceptualised the project.  
Data Safety and Monitoring Plan  
 
The eliciting of patients' experiential world of HIV/T2D co-morbidity may trigger 
unintended consequences such as the need for the researcher's sympathy or support. ln 
this regard, the researcher will have a resource list  at hand for referrals such as who the 
participant can go to for counselling, food relief or employment opportunities. Where the 
researcher is unsure, she will take the contact number for the participant and inquire with 
the clinic staff on how such an issue can be addressed and then inform the participant of 
the outcome. An "Early Stop" sheet will be devised which records "refusals" and 
"unfinished interviews" (Appendix 5). Refusals will be defined as those potential 
participants who refused to be part of the study after the purpose is explained to them. 
"Unfinished interviews" will be the participants who would have declined from 
continuing with an ongoing interview, and those patient participants requiring emergency 
medical attention. In this regard, the researcher will stop an interview and resume if 
possible, after health workers have attended to the participant. If the participant is 
incapacitated to continue, the researcher will record it on the Early Stop sheet. The reason 
for each early stop case will be noted on the sheet as well.  
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Data Analysis  
 
Data analysis will start during the data collection phase. This will enable the researcher to 
identify questions that need refinement in the interview guide and allow richer responses 
in later interviews on the management of HIV/T2D co-morbidity. Thematic analysis will 
be applied to the transcripts which is a comparative process of  the various accounts that 
are gathered and finally grouped into themes (Green and Thorogood, 2013, Bazeley, 
2013). To elaborate in thematic analysis, the researcher first familiarises him/herself with 
the data through reading and re-reading the data. Second, codes or labels are assigned to 
text with similar meaning through a process of re-analysing the data. A codebook will be 
developed which comprises of six basic components:  the code, a brief definition, a full 
definition, guidelines for when to use the code, guidelines for when not to use the code, 
and examples (Hennink et al., 2010). This will be beneficial to both the researcher and 
the supervisor, as it will allow collaboration between the two to validate the codes and 
refining these codes. A codebook will also assist in the third step of categorisation where, 
similar codes are merged into categories; with dissimilar codes also standing as 
individual categories. Finally categories are arranged into themes which reflect the 
underlying meaning of all the data analysed (Hennink et al., 2010).Throughout all the 
four stages the researcher will continuously search for new meaning in the data.  
 
In this study, Nvivo computer software will be used to manage data emerging from the   
transcriptions and analysis of the interviews.  To anonymise data, the participants will be 
assigned numerical identifiers, from participant 1 to 16. In instances where participants 
disclose names of people during the interview, a pseudonym will be used instead. In 
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order to minimise risk of having inaudible interviews and deleting interviews, the 
researcher will do a voice test before each interview and the recording will be copied to 
the researcher's computer shortly after the interview. To prevent data from being 
retrieved easily by anyone, the researcher will only share information with her 
supervisors, use her personal computer and protect it with a password.  
Ethical considerations 
Potential risks and discomforts and minimising risk 
In this study, potential risks and discomforts may be physical and psychological to the 
patient participants due to them having multi-morbidities. The research participants may 
experience fatigue due to the fact that before consultation for T2D, patients may be 
required to not have eaten in the morning so that pre-meal glucose levels can be tested 
(Koschinsky et al., 1997). Strength can be regained only after eating and in such cases, if 
a participant is weak he or she will have the interview after consultation and after he or 
she would have eaten some food. Psychologically, participants may already be 
overwhelmed with the workload that comes with their multi-morbid conditions. This may 
result in triggering emotions of helplessness and hamper the research process. In this 
regard, if the participant becomes very distracted and cannot respond to the researcher, 
the researcher will find out before the interview whom she can refer patients to if this 
situation arises. In an emergency case of a research participant needing urgent medical 
attention a nurse will be informed before each patient interview to be on stand-by. 
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Potential benefits  
 
There are no direct benefits to the research participants but having the opportunity to ‘tell 
their stories’ and to have someone to listen to them can be therapeutic and satisfying for 
them. Since findings will be published, it may strengthen the health system in managing 
multi morbid conditions. To the health services in Khayelitsha, the health workers will be 
more aware of the issues that concern multi-morbid patients and they will see how they 
can revise their current clinical practices. This will also allow future patients to receive 
better healthcare services that will strike a balance between their treatment and general 
well-being. 
Privacy and Confidentiality 
 
To maintain confidentiality, transcriptions and reporting research findings will use unique 
identifiers so that the identity of the research participants remains unknown. All 
electronic data will be stored in the researcher's personal computer and will only be 
accessible to the researcher, supervisors and other members of the larger team. Data will 
be disposed after publication of the study findings.  
Autonomy 
 
Autonomy implies to respect the rights of the individual. Respecting the rights of the 
individual requires the researcher to value the worthiness and dignity of the participant 
from gathering information and to the time of publishing research findings. In this study, 
the researcher will ensure that the rights of both the patient and health worker participants 
are not infringed.   
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Informed Consent Process 
 
The researcher will facilitate the process of obtaining informed consent for the patient 
participants; with the translator assisting in translations from English to Xhosa where 
necessary. Verbal and written consent will be sought in the private room where 
interviews will be held, after the purpose of the study is explained to each research 
participant. Timing for giving consent by the research participant will be before 
consultation. However, informed consent will be a continual process during the interview 
as discomfort may arise at any given time; which may warrant an early stop.  As the 
study will consist of adults who have the capacity to make own decisions, there will be 
no need to consult with family; but if the participant wants to do so, he or she will be free 
to do so.  
 
Health workers will give their verbal consent in the first contact they have with the 
researcher; which is during the recruitment and sampling phase. Written consent will be 
sought in the private room where interviews will be held before the interview starts. 
 
Capacity to consent  
 
Not all adults have the capacity to consent as some may suffer from mental illness or 
severe depression that impairs their ability to make decisions. As such, in the research 
project, patients who are clinically diagnosed to be mentally ill or severely depressed at 
the time for data collection will not be included in the study. Only adults who have the 
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capacity to make personal decisions reasonably will be part of the study; which applies to 
both patient and health worker participants. 
Comprehension of information, consent and assent forms 
 
To determine whether the participant understands the information provided or not, the 
researcher will ask the participant if he or she has any questions after the researcher states 
the purpose of the study. If there is a need, clarification will be done by the researcher if 
the purpose may have been misunderstood; before continuing with the interview process. 
As research participants will be drawn from the adult population, adult consent forms will 
be used. The consent form will be translated into Xhosa if need be; for both patient and 
health worker participants so that the research participant has a very clear understanding 
of what the research is about and  this will assist in the participant making a well-
informed decision into continuing with the research or not.   
Reimbursement for Participation 
 
A food voucher to the value of R100 will be given to patient research participants only as 
a token of appreciation. 
Dissemination  
At the end of the study, research findings will be publicised to suit different audiences 
because, "the end product of applied qualitative research on public health should be to 
give public voice or visibility to private or hidden issues, cast new light on puzzling 
questions, make invisible problems clear and make health problems more 
understandable" (Ulin et al., 2005). Formal presentations will be done to the Western 
Cape Department of Health to discuss the applicability of the CCM in multi-morbidity 
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management; and integrating it with the current ICDM.  Presentations will also be done 
to health workers at the clinic. A mini thesis will be submitted to the university, which 
after being assessed may be open to others in academia for study purposes. A journal 
manuscript will also be written and submitted to publicise the findings among other 
researchers globally. 
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A health system consists of  building blocks (WHO, 2007) that have health workers, 
patients and other stakeholders at the centre to influence health care service delivery (De 
Savigny and Adam, 2009). In chronic disease management, a call for integration of care 
for communicable diseases (CDs) and non-communicable diseases (NCDs) was proposed 
through the conceptualisation of the Innovative Care for Chronic Conditions (ICCC) 
model (WHO, 2002). Theoretical studies that echo health systems strengthening in low 
and middle-income countries (LMICs) with a shift from vertical disease programs to joint 
management approaches that account for NCDs and CDs convergence (Marais et al., 
2013, Bates et al., 2015); and  acknowledge the ICCC model (van Olmen et al., 2012, Oni 
and Unwin, 2015) have been widely publicised. However, few empirical studies have 
reported on how health systems of different LMICs have fully integrated chronic 
diseases' health services to their current clinical practices (Amuna and Zotor, 2008, 
Pastakia et al., 2013, Aantjes et al., 2014, Wroe et al., 2015). Instead, most report on co-
morbidity in non-communicable diseases (Bhojani et al., 2013), communicable diseases 
(Rich et al., 2012, Legido‐Quigley et al., 2013) or a combination of a non-communicable 
disease and a communicable disease ( (Kirui et al., 2012).   
 
As hypotheses (hereafter, theory) and conceptual diagrams (hereafter, theoretical 
frameworks) can be formulated from research findings and be used to further shape 
future research and a country's healthcare interventions or programmes (hereafter, 
healthcare models) (Eccles et al., 2005, Campbell et al., 2007); the aforementioned 
empirical studies may or may not have been shaped by certain theory or theoretical 
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frameworks. A further analysis of the use and non-use of theory and theoretical 
frameworks is imperative to understand how healthcare models for chronic diseases in 
LMICs may be more responsive to local contexts. In this scoping review, with reference 
to HIV and type two diabetes (T2D) services the organisation and management of 
chronic services including patients’ experiences in the organisation of these chronic 
services for LMICs will be described.  
 
HIV and type two diabetes co-morbidity (hereafter  HIV/T2D) will be used as an 
example of the convergence of CDs and NCDs due to the complexities which come with 
management of each condition (Goedecke et al., 2013, Haque et al., 2005). LMICs 
excluding South Africa and a separate section for South Africa will be presented because 
South Africa’s chronic care system is the focus of the study. Although still in its infancy, 
chronic care services in the South African health system have been redesigned to 
integrate chronic care for NCDs and CDs at primary healthcare (PHC) level. The ICCC 
and the Integrated Chronic Disease Management (ICDM) frameworks that 
conceptualised this reorganisation will provide the basis of interrogating this 
phenomenon further. However, across LMICs including South Africa, patients' 
experiences which entail workload and capacity issues are overlooked amidst the 
organisation and management of chronic services; which a theoretical framework 




Literature search strategy  
Published literature was searched on Medline via PubMed as depicted in the typology 
below (Fig B1). Six key search terms were "HIV and type two diabetes co-morbidity", 
"HIV and NCD co-morbidity", "HIV and diabetes mellitus co-morbidity", "chronic care 
models in low to middle income countries", "diabetes mellitus models in low to middle 
income countries" and "HIV care models in low to middle income countries".  Articles 
included for the review had to have an abstract, published in the last ten years, human 
species and in English.  Repeated papers from the previous search term were removed 
before reviewing literature on the following search term. 
 
 A total of 246 papers were initially identified and 40 papers were finally selected. 
Excluded literature was on papers that just gave a description of risk factors for chronic 
conditions or were mainly epidemiologic in nature, papers which did not describe either 
HIV or T2D as one of chronic conditions under investigation, papers which were not 
focused on LMICs; and economic evaluations. The search was refined further by 
reviewing references from key papers; reviewing relevant methodological papers on 
health systems and reviewing publications by the Department of Health on chronic 
services, with special focus on HIV/T2D.  
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Fig B1: PubMed search strategy 
Models of Chronic Care in LMICs and South Africa 
Definition of chronic conditions and co-morbidity 
The term "chronic" has numerous definitions which include, a long-term health related 
state, illness which lasts for three to six months or longer (Porta et al., 2014); or which 
may result in permanent residual disability (Modeste and Tamayose, 2004). A further 
description of chronic conditions encompasses non-communicable conditions, persistent 
communicable conditions, long-term mental disorders and ongoing physical impairments 
(WHO, 2002). Co-morbidity is defined as a disease that coexists in a study participant in 
addition to the index condition that is the subject of the study (Porta et al., 2014). 
However, as the focus of the review is on healthcare provision  of chronic conditions, 
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using HIV/T2D as an example, the co-existence of these two conditions will not be 
viewed as one condition more central than the other (Boyd and Fortin, 2010). 
Chronic care in low to middle income countries 
 
The first category of models of chronic care identified in LMICs describe the 
organisation and management of health services within health facilities and they all had 
the weakness of not acknowledging patient workload and capacity in managing these 
morbidities. The Indian AIDS Initiative, Avahan, between the government and an 
international agency; was a population level intervention of HIV prevention strategies 
across six states in India to reduce HIV transmission especially among pregnant women. 
Programme evaluation after five years showed that the rate of new infections across the 
six states benefitting from the programme had dropped (Ng et al., 2011). Although health 
outcomes were improved, the interactions were mainly at macro (national) and meso 
(local health system) levels of the health system and the experiences at the micro level 
(individual), in this intervention are unknown. In Kenya, the organisation and 
management of chronic services is done vertically as noted in a study on HIV/T2D co-
morbidity in rural Western Kenya. The descriptive study provided data on HIV/T2D co-
morbidity and also TB/T2D co-morbidity (Kirui et al., 2012). Similarly, with the Indian 
initiative, how patients experience living with co-morbidities on a daily basis was 
unreported. 
 
A second category of models of chronic care identified in LMICs were patient-centred. 
Patient-centred interventions focused on how involvement of the home environment can 
influence health outcomes and highlighted on the patients' workload and capacity issues 
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that come with chronic care; but missed the interaction of patients with the organisation 
and management of services at health facility level. In India, empirical studies (Weaver et 
al., 2015, Bhojani et al., 2013) investigated patients' experiences for living with T2D; and 
T2D and hypertension respectively.  These studies presented evidence on the need to 
employ biocultural frameworks in improving health outcomes for women living with 
T2D and improving chronic care for the urban poor especially in government facilities. 
However, the biocultural frameworks referred solely to social pathways as the only form 
of workload; yet issues such as physical and mental functioning, socioeconomic 
resources and literacy can also influence health outcomes.   
 
The use of patient narratives to understand how people experience and understand T2D 
across income groups in Delhi, brings to the fore issues of self-care, access and utilisation 
of healthcare services in this region. Findings revealed that lower-income T2D patients 
not only had higher rates of depression compared to higher-income T2D patients, but 
were more likely to delay healthcare and therefore develop diabetes complications due to 
poor access to medical care (Mendenhall et al., 2012).  A balance was hence, maintained 
on how socio-economic status and how the organisation of chronic care services at PHC 
level influenced self-management of T2D. However, depression was the only outcome of 
measure and the plurality and complexity of health outcomes that come with living with 
T2D is not validated.   
 
Conclusions drawn from systematic reviews on HIV programmes in LMICs indicated 
redressing of healthcare provision at facility level. The first review was on HIV 
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programmes for vulnerable groups such as female sex workers which recommended 
interventions that not only focused on preventive care for HIV and STIs but other 
women's health issues such as screening for cancer and gender based violence (Dhana et 
al., 2014). Another review was on the integration of TB and HIV services were referrals 
within health facilities was key to optimal health outcomes for patients with HIV/TB co-
morbidity (Legido‐Quigley et al., 2013). HIV voluntary counselling and testing(VCT) 
programmes also revealed that different modalities of VCT were implemented in LMICs, 
which was not only facility based (clinic testing and counselling) but extended to the 
micro level of the health system (home-based testing and counselling) resulting in 
reduction in risky sexual behaviours (Fonner et al., 2012). However, in all these reviews 
patients’ workload and capacity to engage in these interventions were unexplored.  
 
A third category of chronic care models included both organisation and management of 
services at health facility level and were patient-centred but the models had different 
shortcomings to address holistically patients’ capacity to manage their chronic 
conditions. In Rwanda, a partnership of NGOs and Ministry of Health was pivotal in 
providing community based ART programmes in rural health centres that were largely 
driven by community health workers (CHWs). In this study, HIV patients were supported  
through free provision of ART, TB screening and treatment; nutritional and social 
support; and transport allowances for clinic visits (Rich et al., 2012) which resulted in a 
high retention rate of adults enrolled in the ART programme. In Kenya, diabetes and 
hypertension care in rural areas entailed in one programme, concerted efforts between the 
private sector and Ministry of Health to offer home based care programmes for HIV and 
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NCDs; and in another programme, community based screening. In the former, HIV 
counsellors were equipped to undertake door-to door diabetes and hypertension 
screening; whilst in the latter, the district hospital staff did screening at the health facility 
and provided treatment for people diagnosed with these two conditions (Pastakia et al., 
2013). In these two experiences, goals were set at meso level of the health system, and 
the intervention was successful; but how the villagers experienced these interventions 
was unreported.    
 
A systematic review indicated how collaboration between private partnerships; and 
between private partnerships and governments of various LMICs were successful in 
implementing various T2D interventions. Some interventions appealed to improving 
health workers' provision of care for T2D through further training; and others were 
patient centred programs  such as support and education  groups relevant to certain 
settings (rural or urban) and  people of similar  age-groups and socioeconomic status 
(Esterson et al., 2014). Whilst health education and literacy have been seen to be 
important especially in T2D care, the patients’ abilities to fully understand their 
engagement in the intervention are unknown. 
 
In the Philippines, the adapted diabetes self-management education and support 
(DSME/S) framework was designed for diabetes reorganisation at PHC level. The roles 
of health workers were enlarged (Dubois and Singh, 2009);  to improve chronic care 
through the support programmes to patients at the PHC and at home. This entailed health 
workers engaging both stable and unstable patients in self-management health education; 
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and offering screening and support services for diabetes (Ku and Kegels, 2014). Though 
this experiment went beyond testing organisation and management of health services at 
facility by giving patients a platform to share their experiences of chronic management, 
there was no control group to test the effectiveness of the model. The "context-adapted 
chronic care model-based service delivery model" (Ku and Kegels, 2015) conceptualised 
PHC re-organisation and "assisted" self-management  of both stable and unstable chronic 
patients in low income countries but there are no clear linkages  in the model of clinical 
management support and system support and strengthening across the three levels within 
the health system. 
 
A decentralised model in the provision of ART in some LMICs was noted where 
treatment could be initiated and maintained at any point of care (hospital and PHC) and at 
home. However, partial decentralisation was not seen as ideal as it sometimes contributed 
to loss to follow up (Kredo et al., 2013). Further insight is also needed on knowing how 
patients experienced the workload and capacity issues that contributed to variations in 
loss to follow up. 
 
Conceptual work also shows that reorganisation of chronic services was underway in the 
Pacific. A strategic framework consisting of four phases was proposed as a response to 
the increasing chronic conditions in the region (Robinson and Hort, 2012). Also, through 
expanding coverage of "Vital Registration" to account for cause of death statistics for 
NCDs, health information systems were to be strengthened to provide statistical data of 
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NCDs (Amuna and Zotor, 2008). This transition also reflects little understanding on how 
people experience health services reorganisaton. 
A unique case of Zambia (Aantjes et al., 2014) reveals that general understanding of 
patients’ workload and capacity issues may have been understood by inclusion of the 
patients in policy formulation.  Agenda setting which entails identifying a problem and 
prioritising it (Buse et al., 2012)  was undertaken, to address the convergence of CDs and 
NCDs in the Zambian health system; and interaction of stakeholders was at the meso and 
micro levels of the health system. These stakeholders included the government at national 
and PHC level; non-governmental organisations (NGOs) which largely drive CD and 
NCD services at community level through programmes such as Community and Home 
Based Care and patients. 
Chronic care in South Africa 
In South Africa, chronic care is guided by two theoretical frameworks- the Innovative 
Care for Chronic Conditions (ICCC) model and the Integrated Chronic Disease 
Management (ICDM) framework (DoH, 2013). The ICCC model is built on the 
previously widely used Chronic Care Model; which largely gave a clinical perspective in 
managing chronic conditions (Wagner et al., 1996, Wagner, 1997). The ICCC 
hypothesises that optimal health outcomes for chronic conditions are realised by people 
within an enabling health system environment. Role players are patients and families, 
health care teams, and community supporters who form functional interrelationships 
within the health facility, community and policy environment.  Each role player is seen to 
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be informed, motivated and prepared to manage chronic conditions; and communication 
and collaboration are maintained among all levels of care (WHO, 2002). 
 
The ICCC further posits that current health systems prioritise acute care instead of 
chronic care that creates challenges that cut across micro, meso and macro levels of the 
health system. To address the limitations envisaged in the micro, meso and macro levels 
of the health system; the ICCC model has, six guiding principles which are: evidence 
based decision making by health workers, focus on public health as opposed to individual 
care, implementation of chronic conditions prevention strategies, offering quality 
healthcare services, integration of chronic conditions services and adaptability to changes 
in burden of disease. These innovations may only be exhibited by decision-makers taking 
strategies which support a paradigm shift, managing the political environment, building 
integrated health care, aligning sectoral policies for health; using health care personnel 
more effectively; patient-centred and family centred care; supporting patients in their 
communities and emphasising prevention (WHO, 2002). 
 
The ICCC has been adapted to fit the South African context through formulation of the 
Integrated Chronic Disease Management (ICDM) framework which is aligned with 
objectives of the national strategic plans on the organisation and management of  NCD 
and CD health services (DoH, 2011, DoH, 2013). The ICDM is a model of managed care 
for both communicable and non-communicable diseases that promotes optimal clinical 
outcomes for people living with single to multi-morbid conditions at primary healthcare 
(PHC) level through four phases of PHC re-organisation, clinical management support, 
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"assisted" self-management and system support and strengthening. Pilot projects were set 
up in 42 selected PHCs in three provinces (North West, Mpumalanga and Gauteng) in 
2011 and are suggested to be the model of care for NCDs.   
 
The components of PHC re-organisation address operational efficiency such as 
improving patient process flow and integrated care for patients with CDs and NCDs. 
From the search strategy used, no empirical studies could be traced which reported on the 
integrated care for NCDs and CDs within the PHCs in South Africa except for two 
studies that gave prevalence data on both CDs and NCDs (Mash et al., 2012, Oni et al., 
2015). The lack of data on the convergence of CDs and NCDs may be ascribed to  the 
reorganisation still in its’ infancy and  how separate national strategic plans on the 
organisation and management of  NCD and CD health services (DoH, 2011, DoH, 2013) 
are translated at the point of care. 
 
 At the level of the health workers, devolution of authority and responsibility as a form of 
decentralisation (Bossert, 1998) is evident as the PHC operational manager leads and 
controls change in service delivery within the PHC and the community. From the nurses 
and medical practitioners  job descriptions, role substitution and role delegation is evident 
(Dubois and Singh, 2009) as PHCs are largely nurse-driven with medical practitioners 
only meant to consult referred patients and mentor professional nurses. Clinic committees 
stand as PHC representatives for the community leaders and community members; but 
they face challenges as promoters of community participation in health services  mainly 




Clinical management support are individuals who foster teamwork and collaboration 
among health workers at PHC, district and sub-district levels to ensure quality of care and 
realisation of optimal clinical outcomes for chronic conditions. The ICDM champion is a 
key figure among clinical management support staff as he or she is the trainer of clinical 
practice guidelines (PC101) for chronic conditions. Stable chronic patients benefit from 
"assisted" self-management driven by ward-based outreach team of community health 
workers (CHWs). Health workers provide health promotion services at chronic patients' 
homes and at the PHCs. This may be alluded to  successes such as CHW's effective 
management of hypertension and T2D (Ndou et al., 2013), HIV/ TB and for other priority 
diseases in South Africa; but challenges which come with change in organisational 
culture have to be addressed first (Schneider et al., 2015). Services will also be extended 
at population level with adolescents by school health teams. 
 
System support and strengthening for the PHC will consist of human resources, health 
information, medicine supply, equipment, leadership and advocacy which are the other 
five building blocks of action viewed to strengthen health systems (Gilson, 2012). 
Innovations in health information systems have already been identified where a simple 
offline electronic version of the paper register is used for monitoring antiretroviral 





Towards a working framework to understand patient workload and capacity: the 
Cumulative Complexity Model  
 
The ICCC model has been subject to scrutiny for not accounting for patient workload and 
capacity that come with multi morbidity and modifications to the framework have been 
proposed (Oni et al., 2014). In addition, in the ICDM, the emphasis is on job descriptions, 
networking, and support services but very little is known about how patients experience 
this reorganisation. The CCM becomes unique in that it was developed for health workers 
to assess patients' experiences in living with chronic conditions and encourage health 
interventions that are responsive to the complexities of  managing these chronic 
conditions (Shippee et al., 2012).  Patients are viewed to have workload of demands that 
come with living with co-morbid conditions. These include patient and non-patient tasks 
and responsibilities faced daily such as self-care, job and family.  Their capacity to meet 
this workload of demands is determined by a number of factors such as physical or 
mental functioning, socioeconomic resources, social support, literacy, and attitudes or 
beliefs. The interaction of workload and capacity affect patients’ access and utilisation of 
healthcare services and self-care; which influence health outcomes. Health outcomes are 




The literature reviewed reflected that chronic care in LMICs is based on service delivery 
plans that may or may not be guided by specific theory or theoretical frameworks. Three 
forms of models for chronic care services identified for LMICs focused on the 
organisation and management of health services at health facility level; patient-centred 
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interventions; and chronic care services that include both organisation and management 
of services at health facility level and the patients’ experiences. These models were 
centralised to certain geographical locations, with some being the standard of practice 
across similar settings in the same country. 
 
 In South Africa, as the integration of chronic conditions in the health system is still in 
early stages, scant data were available to reflect patients’ experiences in the 
reorganisation. From the shortcomings of the chronic care models for LMICs including 
South Africa in incorporating patient experiences, measurement of workload and 
demands of multi morbidity (HIV and T2D) using the Cumulative Complex Model was 
identified as a potential tool to guide development of interventions to improve care in the 
context of multi morbidity. 
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A qualitative study on the experiences and perspectives of public sector patients in 





Background: The South African health system is experiencing a convergence of 
communicable and non-communicable diseases. As the incidence rates of co-morbidity 
continue to rise, the Integrated Chronic Disease Model (ICDM) which is a modification 
of the Innovative Care for Chronic Conditions (ICCC) to fit the South African health 
system; proposes health services that are oriented towards integration of chronic services. 
Little is known about how chronic patients with multi-morbidities currently experience 
the (re)-organisation of health services and what their perceived needs are in order to 
enhance the management of their conditions both at point of healthcare and in their daily 
lives. 
Methods: Qualitative methods were applied in the study. Individual interviews were 
done with a purposive sample of 10 adult patients who have HIV and type two diabetes 
co-morbidity (HIV/T2D) and 6 health workers who provided health services to this group 
of patients at a primary health care facility in Cape Town. Interviews were recorded and 
transcribed. Analysis was aided by the NVivo computer program and thematic content 
analysis methods were applied. 
Results:  Shippe's Cumulative Complexity Model (CCM) was used as a testing tool to 
explore patient workload and capacity to manage chronic conditions whose linkages are 
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not clear in the ICCC model and ICDM.  Despite the burden of illness and burden of 
treatment, which come with living with multi-morbidities, patients were well adjusted 
with self-care. However, health workers' experiences from practice indicated that patients 
HIV/T2D management varied as not all patients were well-adjusted.  Both patients and 
health workers also shared strategies, which were supportive and less enabling of 
integrated care for chronic conditions.  
Conclusion: The CCM, largely is a suitable framework to explore multi-morbidity as it 
captures most of the themes around "patient workload" and "patient capacity". In this 
setting, the meaning attached to the themes under these two concepts suggested that what 
may be classified as patient workload or capacity in the CCM; would not be viewed by 
other participants as patient workload or capacity.  More country examples are necessary 
to show the effectiveness of integrated chronic care health services in improving patient 
workload and patient capacity that comes with living with multi-morbidity. This would 
entail not only reorganisation of health services at the health facility; but taking into 
account patients' lived experiences and feedback in this reorganisation. 
 
Keywords: integration, Type two diabetes, HIV, multi-morbidity, workload of demands, 
capacity,  
 Background 
An ideal health system is built on six blocks which include: governance, information 
systems, finance, service delivery, human resources and; medicines and technologies [1]. 
The ultimate goals include being responsive to the health needs of the people, promoting 
fairness in distribution of health services, protection of families from catastrophic health 
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expenditure and respecting people. Health systems in low and middle-income countries 
(LMICs) are burdened by the increasing prevalence of multi-morbidity, with growing 
numbers of people living with both communicable diseases (CDs) such as HIV and TB 
and non-communicable diseases (NCDs), such as hypertension and diabetes. In response 
to the need for strengthening health systems for chronic care, the Innovative Care for 
Chronic Conditions (ICCC) model was conceptualised by WHO in 2002, which 
emphasises the importance of offering quality healthcare services, the integration of 
chronic conditions services and adaptability to changes in burden of disease [2].  
Literature on LMICs gives evidence of repeated calls for a shift from vertical disease 
programs to joint management in order to reduce the burden of CDs and NCDs on both 
the individual patient and the health system [3-8].  In South Africa (SA), the integration 
of CDs and NCDs is guided by the Integrated Chronic Disease Management (ICDM) 
framework [9]  which is an adaptation of the ICCC model to the local context. The ICDM 
is aligned with the objectives of the national strategic plan on the organisation and 
management of health services for CDs and NCDs [9, 10]. It is argued that optimal 
clinical outcomes for people living with single or multi-morbid conditions can be 
achieved through primary healthcare (PHC) re-organisation involving improved clinical 
management support, clinical practice guidelines for integrated care and the use of 
community health workers to assist patients with self-management (ICDM Manual). 
However just as in Zambia, Malawi and the Pacific, [3, 11, 12] PHC re-organisation in 
South Africa is still in its initial stages and limited empirical work exists on the 
convergence of the CD and NCD epidemics.  
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HIV and type two diabetes (T2D) co-morbidity is an illustration of  CD/NCD 
convergence in the South African health system due to the complexities faced in effective 
management of the conditions by both health workers and patients [13] [14, 15] and in 
the Western Cape, are ranked  to be the top two causes of mortality [16].  Only two local 
studies have reported on the prevalence of HIV/T2D co-morbidity. A cross sectional 
study in the Western Cape Province on multi-morbidity (HIV, TB, T2D and 
hypertension) showed the highest prevalence of multi- morbidity in the 36-45 and 46-55 
age group; with T2D patients and HIV patients both having hypertension as the major co-
morbid condition [17]. Nationally, Mash et al (2012) reported on morbidity in primary 
healthcare across all age groups and reflected that HIV/AIDS and T2D were both ranked 
third for reasons of primary care diagnoses [18]. 
However, healthcare interventions or programmes (hereafter, identified as models for 
chronic care) proposed in LMICs fail to address the organisation and management of 
HIV/T2D services in totality. Health facility oriented models [19, 20], which are 
conceptualised and implemented within health facilities, do not take into adequate 
consideration  patients’ lived experiences in the organisation of chronic healthcare 
services. Patient-centred interventions [21-23], which focus on the how the patient's 
home environment influences self- management of chronic conditions, miss the 
interaction of patients with the organisation and management of services at health facility 
level. Health facility-patient centred models [24-28], which are meant to be a 
collaboration of health workers and patients in managing chronic conditions, have 
limitations in fully addressing patients' capacity to manage their chronic conditions. 
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These factors are largely a lack of feedback from patients on how they experienced these 
interventions such as patients' capacity to understand fully their involvement or non-
involvement in the intervention and reasons for loss to follow up. 
 
 The Cumulative Complex Model (CCM) [29] attempts to address these constraints as it 
is a "patient-centered model intended to guide improvements in the analysis and 
evaluation of patient complexity and promote innovative care delivery for complex 
patients". Patients are viewed as having a workload of demands that come with living 
with co-morbid conditions. These include daily tasks and responsibilities related to self-
care, job and family.  Their capacity to meet the workload of demands is determined by 
their physical or mental functioning, socioeconomic resources, access to social support, 
level of literacy, and attitudes or beliefs. The interaction of workload and capacity, affect 
patients’ access and utilisation of healthcare services and ability for self-care; which 
ultimately influence health outcomes. Health outcomes are also influenced by the burden 




The purpose of this study was to explore the experiences and perspectives of public 
sector patients in Cape Town in managing the workload of demands of HIV /T2D co-
morbidity; and how this influenced their capacity for effective self-management.  The 
study was conducted in Khayelitsha, a peri-urban, largely informal township of 
predominantly black South Africans in Cape Town. It is one of the eight sub-districts in 
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the Cape Metropole and although 62% of the labour force is employed, 74% of 
household income is less than R3 200 per month.  45% of households live in formal 
houses; 62% of households have access to piped water in their yard and 81% of 
households use electricity for lighting [30].  
Patient participants were drawn from Ubuntu Clinic and the general clinic, which provide 
HIV and TB services; and primary health care for all other diseases such as T2D 
management, respectively.  These two clinics are situated at Site B PHC facility.  Health 
providers were drawn from Ubuntu Clinic and the general clinic.  At Ubuntu Clinic, the 
prevalence rates of hypertension, HIV, T2D and TB, indicate that HIV and T2D are 
ranked second and third respectively with respect to co-morbid chronic conditions. Also, 
HIV accounts for 38.4% and T2D 18.3% of the total adult cases. [17]. 
 Ethical approval for the study was granted by the Western Cape Department of Health 
and the Human Research Ethics Committee of the University of Cape Town (HREC Ref: 
314/2015). A qualitative, cross sectional study design was used. For participants who 
verbally accepted to be part of the study, written consent was obtained (Appendices 1 and 
2).  Convenience sampling was used for both patient and health worker participants 
because the researcher had to rely on available participants at the health facility. 
Purposive sampling was also done as the researcher drew participants from the health 
facility based on the eligibility criteria.   
 
Inclusion criteria for patients included: having both HIV and T2D co-morbidity; having 
initiated antiretroviral therapy (ART) and also be on treatment for T2D; be between 35 - 
65 years old; capable and willing to provide informed consent, and be interviewed in 
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simple English. As Xhosa is the dominant language in Khayelitsha, a translator was 
present in each patient interview to provide translation assistance if the research 
participant needed to ask or answer questions in the vernacular. Equal numbers of male 
and female patients were recruited. Six health workers were also recruited in the study 
which included two doctors, two clinical nurse practitioners (CNPs) and two HIV 
counsellors. All health workers were from the general clinic, except one CNP from 
Ubuntu clinic. The inclusion criteria included had to be working with adult chronic 
patients; willing to communicate in simple English and capable and willing to provide 
informed consent.  
   
In-depth, one-on-one, semi structured interviews were conducted with ten patients to 
elicit lived experiences of managing chronic co-morbidities; and six health workers to 
elicit descriptions of the role they played in ensuring effective self-management among 
their patients. Patients were asked what they had to do to care for their health, the 
challenges they faced in meeting these demands and the factors that helped them. Health 
workers were asked how they provided care for HIV/T2D patients, the challenges 
experienced in this interaction and how they assisted in developing patient capacity. 
Interviews were guided by two separate semi-structured questionnaires for patients and 
health workers (Appendices 3 and 4). The questionnaires were based on the themes of the 
CCM; together with two other empirical studies that explored the concepts of "patient 
workload" and "patient capacity" (May et al 2014; Eton et al, 2015). Each interview was 
face to face, held in confidence in a private room, audio taped and lasted for 
approximately an hour.  
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Demographic data were recorded for all participants at the beginning of the interview 
(Table 1).  Interviews' transcriptions were done verbatim and in English. At the end of 
each interview, a food voucher to the value of R100 was given to patient participants as a 
token of appreciation. Data analysis commenced during the data collection phase which 
enabled further probing of certain issues based on previous participants' responses. 
Thematic content analysis was applied to the transcripts [31, 32]. This involves the 
researcher becoming familiar with the data through reading the data, reflecting, coding 
and refining codes. Data from participants are then described and compared. Lastly, data 
are extracted and explained by agreeing with, defending or extending existing literature. 
A codebook was also developed [33] and Nvivo computer software was used to manage 
the data.   
 
Table 1: Demographic data of participants (N = 16) 



















Highest education level  
Primary school (Grades 1 - 7) 
Secondary School (Grades 8 -  12) 
Tertiary qualifications: Diploma 
                                      Degree 























Type:  Formal  
           Informal 
 
Ownership: Self 
                   Relative 
 
Water supply: Self 
                       Communal       
              
Energy supply: Electricity 
                        Other 
















Number of patients who specified their 
household members  
Partner 
Child(ren): Minors ( 0 -18years) 






















7  (3-23)  
8.5 (0.5-16) 
 
Position held in health service  
HIV  Counsellors 
Clinical Nurse Practitioners  





Ratio of years of experience  
HIV  Counsellors 
Clinical Nurse Practitioners 





§ongoing or completed 
¤ all employed patients jobs were classified as unskilled labour and all health workers were skilled labour 

 patient data only 

 Formal housing is made of permanent material such as bricks 

 Informal housing is made of temporary material such as steel sheets and plastic 

 solar, wood, paraffin 

 health worker data only 
Results 
 
The CCM as applied to HIV/T2D co-morbidity in this study is presented below (Fig C1); 
and findings of each theme are described below. All themes are tabulated (Tables 4- 8) 
with an example drawn from the partcipants' interviews given. Further explanation of 
these tabulated themes is given in-text. (Whilst submission to a journal requires tables 
and figures as separate files, for the purposes of the thesis and to improve readability, I 











Figure C1: Cumulative Complexity Model for HIV/T2D co-morbidity 
 Theme 1: Perceived patient workload 
1.1 Health care 
Patient and health worker participants reported that at the time of interview, there was no 
integration of care for patients with HIV/T2D multi-morbidity and that the administrative 
and consultative functions for HIV/T2D clinic visits where done in two separate clinics 
on separate days. Of importance, all T2D patients had “club day visits” whilst HIV 
patients where stratified into two distinct groups – “club members” and “non-club 
members" as presented in Table 2. In PHC, the club system was devised for patients with 
a chronic disease who are considered stable that aims to streamline their clinic visits and 
improve waiting times, disease management, and adherence.  
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Table 2: Comparison of scheduled clinic visits for T2D and HIV 
 

























All patients with type 
two diabetes (T2D) 
 
Antiretroviral treatment 




(ART) for less than a year  
-Not virally suppressed 
- Defaulters from ARV 
adherence club  
-Eligible members on 
waiting list 
 





Non- club day 
Collection of 




Waiting in the club room 
for:  
 
Matching of patient 
appointment cards to 
folders by the 
administrative clerk  
                       
Patients' triage  
processes (urine test; 
weight and height; 
blood pressure checks 
PLUS blood sugar test) 
                       
consultation with a clinic 
nurse practitioner (CNP) 
-prescription and 
proceed to pharmacy if 
all the tests’ results were 
optimal  
                   
referral to doctor for: 
-raised blood sugar level 
(>12 or   15mmol/l ) and 
proceed to Trauma unit 
to be placed on a drip   
- raised blood pressure  
 
referral to other health 
professionals such as: 
health educators/ 
dieticians/ social worker/ 
psychiatrist : for further 
guidance, support and 
treatment 













ns at the 
club room 
 
Medication and health 
check visit 
Queuing in different 
waiting areas for:  
 
Matching of patient 
appointment cards to 
folders by the 
administrative clerk 
(reception) 
       
 Patients' triage  
processes (urine test; 
weight and height; and 
blood pressure checks) 
                          
consultation with a clinic 
nurse practitioner (CNP) 
-prescription and 
proceed to pharmacy  
                         
referral to doctor for: 
persistent side effects 
and proceed to 
pharmacy  
                     
referral to other health 
professionals such as: 
 HIV counsellors -  for  
further guidance and 
support 
Dieticians: nutrition 
plans.   
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At the HIV Clinic, the adherence club patients have fixed membership, meaning each 
club consists of the same patients who are approximately 35 per club, and when a patient 
is lost to follow-up, the doctor or CNP assigns another patient who is not in an adherence 
club yet to fill the position.  However, the diabetes club system operated on an open 
membership where patients had to show up on a club day based on the appointment that 
the doctor assigned. This often resulted in overcrowding in the club room and an 
unbalanced allocation of patients for each club day: 
"There are a couple of issues with the booking system...some Monday's we'll get two 
hundred people and then on some Mondays we get eighty people in the club. And the 
reason this happens is because those giving out the dates to come back don't have access 
to the numbers that are coming back on that day."- Participant H2, doctor 
 
The stratification of HIV patients into "ARV adherence club members" and "non-club 
members" was further advantageous for adherence club members than non-club members 
as viewed by both health workers and patients. With this arrangement, club members 
avoided queuing for their folders and for the pharmacy as they went directly to the club 
room on their scheduled days. At the HIV adherence club, patients collected their 
medication and/or consulted with a clinical nurse practitioner (CNP), who would have 
pre-prepared access to each patient's folder.  According to health workers, because of 
these merits there were many patients who wanted to gain access to the club, but 
membership of the club was strictly controlled: patients are only eligible if they have 





The separate HIV/T2D clinics necessitated patients to routinely attend both the HIV and 
T2D clinics once a month and more frequently depending on whether either disease was 
not optimally managed, if adherence levels were low, or if treatment was recently 
initiated (Table 3).  
 
Table 3: Self-reported waiting periods and frequency of visits at T2D and HIV clinics by patients 
 





Whole consultation: +/- 7 hours ( n=10) 
 
Reception :  >1hour (n=2) 
                  
Triage: > 1/2 an hour (n=2) 
                  
Consultation with the doctor: >3hours 
(n=3)  (for follow up or rebooking) 
                  
Health worker's lunch break>1hour (n=1) 
                  
Pharmacy: > 2 1/2 hours  (n=4)  
 






Collection of medication: 





Consultation with the doctor: 
 >1 visit per month (n=3)  
 
Club visit:  
=1visit per four months (n =2) 
 




§Newly diagnosed: <1 year on ART 
Collection of  medication: 
 = 1visit  per month for the first four 
months  
 THEN                   
= 1visit per two months 
 
Short term  HIV counselling: 
 =3 visits in a week OR over 3weeks 
 
Long term counselling:   
6 - 12 months 
 
§Adherence: >1 year on ART 
Collection of medication: 
 =1 visit per two months (n=3) 
 
Consultation with the doctor:  
>1 visit per month (n=6) 
 
 CD4 count tests 
 once annually( n=4) 
 
§





All patient participants, except for one, were frustrated with the long waiting periods at 
the diabetes clinic. When patients were referred to a doctor they were required to wait for 
a further 3-5 hours and when referred to the pharmacy, an average of 2.5 hours. They 
would also wait for an additional hour while the health workers had their lunch break, 
which could be add up to 7 hours. Sometimes, additional appointments were given for 
another day to see the doctor, counsellor or dietician. Patients described the waiting as 
exhausting, frustrating, jeopardy to remunerative work security and a waste of their time 
(Table 4). The situation was worsened particularly when they would either arrive at the 
pharmacy too late to get their medication or to be told that none was available due to a 
stock-out:  
“…Sometimes we don't even receive our medication on that day that you came for the 
clinic. They will give you a letter that tells you, you have an appointment tomorrow 
morning.” – Participant P3, female 
 
Table 4: Patients' clinic-related workload of demands 
Long waiting periods during T2D clinic visits were: 
 (i) exhausting ( n=9)  
"At the pharmacy, the pharmacists are problematic.  It causes stress.  There, you can even sleep there and 
have dreams."                                  -Participant P5, male,  HIV treatment: 6 years, T2D treatment: 15years 
 
(ii) incomplete consultations( n=3)  
“Sometimes I didn’t get my pills because of, they say, “No, the pharmacy is closing at five o’clock because 
today it’s busy.”    
                     -Participant P10, male, HIV treatment: 6 months, diabetes treatment (Type I and II):  23 years 
 
(iii) wasted time for remunerative work ( n=2) 
"If I’m coming here, I'm coming to do the club. I do not feel right because it takes a long time and I am 
supposed to go to work. Every time I must ask for the paper for a doctor. At  work, they’re sick and tired 
(of it) because of every other day I’m coming to produce the paper (sick note)” 
                                                           - Participant P7, male, HIV treatment:9 years, T2D treatment: 5 years 
Frequency of HIV/T2D clinic visits ( n=10) 
“Like this month, I was here on the 27th in the day hospital on the day for the diabetes. Now I will be here 
at Ubuntu (for HIV treatment) on 6th August….It would be better if there was just one date for both. That 
would make it very much easier for us to manage.” 
                                                      -Participant P9, female,  HIV treatment: 14 years, T2D treatment: 8years                                           
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Preparation to go to HIV/T2D clinic (n=10) 
(i) Assisting children before leaving for health facility (n=1) 
“I wake up my little children that need to go to school, and I get things fixed for them so that they get 
ready, and then once I’m finished, 6.30 am, I leave the house come to the clinic 6.45am”  
                                                         -Participant P6, female, HIV treatment: 9 years, T2D treatment: 6years 
 
(ii)Early arrival at the health facility: between 06.30 and 07.00 hours ( n=10) 
"(For) the diabetes clinic...I wake up at 5am... ( at the HIV Clinic) I wake up, at around 8am" 
                                                      -Participant P9, female,  HIV treatment: 14 years, T2D treatment: 8years                     
Transportation (n=8) and travelling time(n=9) to HIV/T2D clinic 
“I use the train. The train it can take up to two hours in bad times. In good times it can take more or less 
thirty minutes…. In Cape Town, I don’t know other places; the train is the cheapest transport. Because the 
taxi is expensive, the bus is also expensive.”    
                                                      -Participant P8, male, HIV treatment: 12 years, T2D treatment: 3years       
 
Diabetes health workers were aware of the burden attending the clinic placed on patients 
and estimated the waiting times at the diabetic clinic to be between 4-6 hours in total. On 
the contrary, one newly diagnosed HIV patient (ART>1year); together with the rest of the 
patient participants who were adherence patients (ART<1year) found the average wait of 
two hours to visit the HIV clinic acceptable.   
 
All of the patients prepared and left their homes for either clinic very early in order to 
queue before the clinic opened at 8am. Most patients reported waking up between 5 and 6 
am. Some patients had to wake children up earlier than usual to prepare them for school.  
Those at some distance from either clinic obviously had to consider travelling time. 
Travelling time ranged from fifteen minutes to an hour. Patients used different modes of 
transport to get to the health facility, depending on affordability that ranged from 
travelling by foot (20%), taxi (40%), train (10%), private car (10%) and unreported 




However, some of the patients noted that they visited the HIV Clinic in the morning as 
well but not very early as there were shorter waiting periods. A health worker described 
how she felt sympathy for a patient with multiple morbidities: 
“She has got about ten medications to take every day. She is taking ARVs and now she is 
coming with a blood pressure of over two hundred (mg/dl) and her blood sugar is 
uncontrolled. So, she is seen here in our clinic (diabetic clinic), she is seen in the 
psychiatric clinic and she is seen at Ubuntu (HIV clinic)" - Participant H1, doctor 
1.2 Self-care 
Health education provided at the two clinics was central in shaping patients' knowledge 
for HIV/T2D management; but adherence to recommendations was often challenging 
(Table 5). Patients spoke of T2D nutrition as they regarded the dietary recommendations 
given by health workers at the two clinics to be the same for managing HIV. This 
included: drinking water instead of fizzy drinks, eating less carbohydrates, using less salt, 
substituting sugar with diabetes sweeteners, having less fatty meat and eating more fruit 
and vegetables. The importance of ideal portion size and frequency of meals on a given 
day were also mentioned:  
“I must eat five times a day. Not like three times a day and making six slices. I must make 
like small portions. But I must make sure my starch is less and less, because according to 
her that is causing my weight to rise."  -Participant P8, male 
 
All patients, except for one, reported that they struggled to afford the recommended 
foods:  
"...your rice is not right, potatoes are not right, mealies are not right and that is the only 
food that we eat. So we can't afford that stuff."- Participant P2, female  
75 
Health workers from both clinics were conscious that many patients could not afford 
buying the required foods and so made an effort to recommend affordable options and to 
explain to patients that often the problem was the way food was prepared:  
“I tell them that you can get these things at the umababela (the street vendor) because 
you get them cheap there; spinach, cabbage. It is also how to cook them at home, 
because they like to fry, they like the beef stock, they like the Aromat….”– Participant 
H5, CNP 
Adherence to physical activity recommendations appeared to be relatively easier: three 
patients mentioned that they had developed a daily routine of walking in order to manage 
T2D. Two other patients said that they danced or jogged to lose weight: 
"There was a time that my weight used to be hundred and ten, but now, ever since I 
started exercising it's gone down to ninety four, so exercising helps. Even if you don't 
have to walk around the place - just being at home and dancing is exercise." - Participant 
P3, female 
Patients highlighted on the need of ensuring personal safety for both HIV and T2D.  For 
HIV patients spoke about safer sexual practices and the need to protect open wounds 
whilst for T2D, one patient mentioned the need for proper foot care, which included 
washing and drying feet properly; and wearing the right shoes "to be safe".  
Taking medication constituted a major task for patients in order for them to maintain 
optimum health outcomes. HIV medication was a 3-in-1 combination pill that was taken 
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orally once a day by nine of the participants; yet one patient reported to have one tablet in 
the morning and two pills in the evening. Seven patients were on insulin for T2D; with 
two of the seven patients; and another two taking three and four extra tablets, 
respectively; orally everyday. Three of the remaining patients took one to three pills per 
day for T2D. Six patient participants had to take medication also for hypertension. 
Patients noted that T2D management required more attention than HIV management as 
high sugar levels could easily impair physical functioning. However, despite the quantity 
of medication, patients did not feel overburdened to manage their health:  
 
"Managing diabetes; it comes naturally to me.  I do it effortlessly, because I find trusting 
my treatment is the key to help me to manage it." - Participant P4, male 
Table 5: Self -care by HIV/T2D patients 
Health education: 
(i) Dietary options for T2D management 
- Knowledge of dietary plan (T2D) ( n=9)  
"We use veggies, fruit; and we don’t mix starch with starch. We eat a balanced meal. And if you use milk, 
you use low fat milk; and don't use sugar and don't use fish oil...you eat half a banana and you only eat 
green apples."                                  -Participant P3, female, HIV treatment: 6 years, T2D treatment: 5years 
 
-Challenges with affordability of required food ( n=3)  
There's times where there are no carrots so you end up cooking rice and potatoes which is what they don't 
want. And sometimes maybe I ha*ve - there's no food and I have five rand, so I buy vetkoek.” 
                                                         -Participant P3, female, HIV treatment: 6 years, T2D treatment: 5years   
 
(ii)  Need to engage in physical activity for T2D management( n=3)  
"I like to jog very much even at my house." 
                    - Participant P10, male, HIV treatment: 6 months, diabetes treatment (Type I and II):  23 years 
 
(iii) HIV/T2D personal safety (n=10) 
It is just me that is focused about not having a cut for their (family) safety, that’s it.” 
                                                         - Participant P5, male, HIV treatment:6 years, T2D treatment: 15 years 
Taking HIV/T2D medication ( n=10) 
"Nothing interferes with taking my medication...If I forgot the time; the alarm is going to remind me it's 
nine 'o clock - I need to take my medication." 
                                                      - Participant P2, female , HIV treatment:16 years, T2D treatment: 6years                                     
Additional morbidities: hypertension( n=6) 
“I’m having a problem with diabetic and high blood pressure. So I need to come to the clinic on a monthly 
basis, once a month”              
                    - Participant P10, male, HIV treatment: 6 months, diabetes treatment (Type I and II):  23 years 
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Family pressures  
(i) Pressures from relatives  (n=1) 
"(When having family functions) I will have one drink, even the meat, normal meat. Since I’ve been 
diabetic, I used to like meat too much. But now one or two pieces for me is enough."  
                                                         –Participant P8, male, HIV treatment: 12 years, T2D treatment: 3years 
 
(ii) Pressures from spouses  (n=3) 
"(The) problem is my wife makes my sugar go up. (She) sometimes shouts at me. I try to tell her the doctor 
said you mustn’t shout at me; you must talk so that I must understand." 
                                                           - Participant P7, male, HIV treatment:9 years, T2D treatment: 5 years        
Stigma (n=9) 
(i) Disclosure of HIV status resulted in stigma from: 
-Spouses (n=2) 
He didn’t even want to see me; didn’t even want wind coming from me towards him.  He had me stay at the 
back of the house.”                                                                                  - Participant P9, HIV-related stigma 
 
-Relatives ( n=1) 
“my sister…phoned me and say listen, there’s one of the ladies within the family she is being going around 
spreading that I’m HIV positive. I say to her that is nothing. I’ve got better things to worry than to worry 
about people saying I’m so and so. Everybody’s sick. They may be sick in a different way, but everybody’s 
sick."                                                –Participant P8, male, HIV treatment: 12 years, T2D treatment: 3years 
 
(ii) Disclosure of T2D status resulted in stigma from: 
-Relatives ( n=2) 
"You see the family is not alright. If you have an argument, they say, "This guy has something." But they 
know I’ve got diabetes. But I hear the way they’re talking, you see. They crush me you know. "Where are 
you getting diabetes but you are small?"                        - Participant P7, male, HIV treatment:9 years, T2D 
 
(iii) Disclosure of HIV/T2D must be restricted to the family unit due to fear of being stigmatised (n=4) 
“When one receives such information, you only tell your family.  That’s the basic.  After that, because 
going and telling everyone that you are sick, that’s not going to do anything for you. Because in the end, 
you are the one who is sick, so you have to accept the fact that now, I have got this and I now I have to take 
my life in this way.”                       - Participant P5, male, HIV treatment:6 years, T2D treatment: 15 years                              
 
At an emotional level, some patients reported that they felt burdened by the difficulties 
their chronic conditions interposed in their relationships with their family members (n=1) 
or spouses (n=3). Spousal challenges included one patient being scolded by his wife; 
another patient could not talk about his HIV status to his partner because she became too 
distressed, fearing that he would die; and a third patient was expected by his partner to 
eat the same food as everyone else in the household, which was not ideal for T2D.  
 
Both patients and health workers raised the issue of HIV/T2D stigma as an additional 
emotional burden. Whilst it was acknowledged that the community was more accepting 
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of HIV than in the past, two patients said that they had not disclosed their HIV and T2D 
status to people outside the immediate family because they feared stigmatisation.  Health 
workers also mentioned that it was difficult for men to discuss sexual health problems 
such as impotence due to T2D treatment:  
“I had a newly diagnosed, family man (with T2D) and he asked me, "Sister, what is going 
to happen to me now. I know there is the loss of libido; because I have heard from so and 
so that he has a problem and now is that going to happen to me?" – Participant H5, CNP 
Theme 2: Perceived patient capacity  
2.1. Positive attitudes 
All patient participants believed positive attitudes were essential to accepting and coping 
with living with HIV/T2D (Table 6). Patients reported to have faith in medical treatment; 
support from family and believed in religious or cultural practices, which helped them 
psychologically to come to terms with their morbidities. The positive diagnoses of HIV 
and T2D were difficult at first, as it affected them physically and mentally, but all of 
them felt that they had adjusted well over time: 
 “That time that I just found out this condition, that I’ve got these diseases; at that time I 
felt, at my lowest. I felt very, very low at that time. I felt like I couldn't accept the way that 
I had to live, but as time went by, I accepted those things and that's what I am now." - 
Participant P1, female 
 
Apart from one patient who was uncomfortable taking insulin, further actions mentioned 
which indicated that patients had incorporated taking medication into their daily routine 
included setting alarms to remind them to take their medication and taking medication 
just before meals. 
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Table 6: Patients' positive attitudes, values and beliefs 
Adherence to treatment (n=5) 
"Yah I do cooking, I do laundry, I clean the house.... it doesn't interfere...I set the alarm...so that if I forgot 
the time, the alarm is going to remind me it's nine 'o clock - I need to take my medication."         
                         -Participant P2, female, HIV treatment: 16years, T2D treatment: 6years 
Family support such as provision of food, encouraging words, companionship and assistance in home 
upkeep especially from siblings, children, parents and some partners ( n=10) 
"So I have got my sister that's there to - that makes sure that I take my medication. At times it's hard and 
even at the hospital she is there for me. She supports me all the way. And if there is a time that I can't make 
my appointment date on, at the clinic - there's time when she comes from home then she gets my 
treatment."                                -Participant P3, female, HIV treatment: 6 years, T2D treatment: 5years 
 
“In Cape Town, at least it’s easy to get food here especially from my brother. It’s very easy to get some 
money and food.” 
                      - Participant P10, male, HIV treatment: 6 months, diabetes treatment (Type I and II):23 years 
God is believed  to be a source of strength in managing multi-morbidity (n=4) 
"I am a religious person myself, so I always trust in the Creator that He strengthens me and He leads me the 
right way.  That is what I would say my pillar of strength is, my way of life." 
                                         -Participant P5, male, HIV treatment: 6 years, T2D treatment: 15years 
Acceptance of positive HIV/T2D and  results 
(i)All patients accepted their HIV results despite being shocked or dismayed at diagnosis (n=10) 
“Since I’ve started (treatment), there’s nothing difficult. The only thing HIV must not involve is tobacco and 
alcohol because the other doctors told me, the alcohol goes to the liver, its cleansed by the liver, the same 
tablets are going to the liver. So if you drink too much you are overworking your liver, which can lead to liver 
failure. So I understand if your liver is not working then that is a problem. So I’m saying, when it comes to 
HIV, you need to avoid tobacco and alcohol."                                          
                                                      - Participant 8, male , HIV treatment:12 years, T2D treatment: 3years 
 
(ii) Patients had varied reactions at initial diagnosis ( n=5)  and present day ( n=9) when diagnosed with 
T2D 
“Before there was a time that I didn't accept that I have diabetes; and things weren't going well for me then. 
In the space of a month I would be in hospital every month; I'd be in hospital very sick, and I've been to 
Tygerberg Hospital, I've been to Khayelitsha. Until I accepted the fact that I have diabetes and the only way 
that I won't return to those hospitals and lay in those hospital beds is  if I take my health seriously and  take 
my medicine - follow my treatment the way it's supposed to be taken and exercise.”  
                                                         -Participant P3, female, HIV treatment: 6 years, T2D treatment: 5years 
Acceptance of mental or physical effects of having multiple morbidities 
-The acceptance of side effects of having multiple morbidities varied at initial diagnosis (HIV (n=7); 
T2D (n=8))   and present day (HIV/T2D (n=10)).  
 
“I was taking d4T (stavudine)… I wasn't feeling right I feel like every, every; my body is painful. So I 
come to the clinic and I tell them that this d4T is not working for me… I was using that d4T, I changed my 
shape.  It changed my shape...to a very tiny person. I wasn't fat. But my structure, was a good structure…. 
when I come to the clinic, some people also complain about the same problem that I'm facing so it's like - I 
told myself that it's - I'm not the only one  so I have to accept it; that I look like this now.”                                            
                                                     – Participant P2, female, HIV treatment: 16 years, T2D treatment-:6years  
 
Ever since I started treatment for HIV…(when ) I go (to the diabetes clinic) for treatment for diabetes and 
high blood pressure, then that is causing more problems, because my blood pressure is too high at the 
time… you know once I sleep during the night maybe I get sometimes terrible dreams or I wake to just go 
for pee. So my heart is beating too much, so fast. So I have to calm down, because once I panic, I start to 
have, I have to walk outside around my house; or to drink some water to calm down”                       




2.2. Health literacy  
Health workers for both clinics viewed health education essential in helping patients 
understand HIV/T2D management. They reported using visual aids, written material and 
group education as health education methods:  
“So they have that pamphlet which they take home. We always tell them, “Put it on your 
fridge, in your face where you'll be able to see; so that something will pinch (remind) you 
if you're still doing what you're not supposed to do.” -Participant H5, CNP 
 
In addition, self-management was discussed with patients individually during 
consultation and in the case of HIV, external advocacy groups such as Treatment Action 
Campaign (TAC) and Mothers2Mothers were stationed permanently at the health facility 
to provide continued HIV education. According to health workers, the level of health 
literacy depended on the patient’s physical and mental functioning, age and education 
levels.   
 
One patient maintained that no health education materials were available in both clinics. 
However, the remaining participants recalled seeing posters or pamphlets on both HIV 
and T2D clinics: 
“There are things that are on the wall, especially in the diabetes club area where they 
show you that you must take twenty five percent starch, twenty five percent protein and 
fifty percent veg. And they show you what kind of alternative sugar that you must use…” 
- Patient P8, male 
 
This patient argued that it was their responsibility to make sure they were well informed:  
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“It also depends on your curiousness. If you are not curious enough then the information 
is going to be far away from you.  You have to be inquisitive and ask how HIV works.” - 
Patient P8, male 
 Other quotes are presented in Table 7. 
Table 7: Assessment of patients' health literacy 
Health literacy( n=9)
(i)Patients managed to keep optimal health outcomes by following T2D and HIV education
“So the diabetes side you always have to follow the law. Otherwise if you don’t follow the law the results 
will show quickly."                         - Participant P6, female, HIV treatment: 9 years, T2D treatment: 6years 
"I know a lot of people that have been diagnosed in the same year as me, they passed away long time ago. 
Because they didn’t come to terms of adjusting like decreasing their alcohol intake, changing their 
behaviour when it comes to women. Now they didn’t like last for long."       
–Participant P8, male, HIV treatment: 12 years, T2D treatment: 3years
(ii)While psychiatry patients were seen to have little understanding of their treatment in practice, in
this sample, a patient older in age and low education level struggled in understanding a positive HIV
status (n=1).
“(A psychiatry patient) has got about ten medications to take every day. So now she is coming with a blood 
pressure of over two hundred (mg/dl) and her blood sugar is uncontrolled. So I ask her how many ARVs 
are you taking. She says three. So I don't know if it is the combination tablet and the others are vitamins or 
are it three different drugs, I don't know."                                                                     - Participant H1, 
doctor 
“HIV I really don’t understand. The clinic guys wouldn’t be able to tell me about HIV. I was told its just 
dirty blood, that my blood is dirty… I was given a huge book to read and there were things like signs. I was 
just told there is no cure. That this is something I have to accept now. There’s only medication that can just 
keep it.”         – Female, 62 years, educated up to Grade 5, HIV treatment: 14 years, T2D treatment: 8years 
2.3. Social support 
A wide array of needs was identified showing the complexities around provision of 
support to patients not only at home, but also in the clinic environment. Family support 
was viewed important by patients. A lack of social support from the family caused 
distress for some patients and negotiating social support for lifestyle change was seen as 
an important ‘task’ for patients on diagnosis (as can be seen in Table 5 - family 
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pressures). However, others spoke warmly of the support they received from family 
members: 
 "There’s a unity of strength...I get full support from my children." - Participant P6, 
female (See Table 6 for related quotes). 
One health worker mentioned that family members were supportive in some areas such as 
accompanying patients on their clinic visits; but another viewed family members less 
helpfully when it came to helping patients with their dietary requirements.  
 
Three patients and two health workers viewed clinical support as adequate for HIV/T2D 
management (Table 8). According to one health worker and one patient, support was 
more established at the HIV clinic than the diabetes clinic because of the presence of 
programmes provided by Mothers2Mothers and TAC. Additionally, HIV patients with 
very low body-mass index (BMI) were referred to a food programme for dietary 
supplementation. At the T2D clinic, one health worker mentioned that the referral system 
was very helpful for patients and two patients appreciated the health education they 
received.   
 
However, four patients were of the view that clinical support was inadequate for multi-
morbidity management. Patients articulated a need for: 1) further information and 
counselling about the implications of having children if one was HIV positive (n=1); 2) 
age-specific, T2D support groups (n=1); 3) greater empathy from health workers for their 
struggles in managing their blood glucose (n=2).  Support programmes were reported to 
be more established at the HIV clinic than the diabetes clinic. One health worker noted 
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that referral of patients to the psychiatrist, dietician or social worker was difficult as these 
services were under-resourced, infrequent and in high demand. Two patients mentioned 
that the bread and soup services during clinic visits for T2D were unreliable and not 
sustained. 
Table 8: Strengths and weaknesses in clinic-related social support 
STRENGTHS 
¤§
Availability of  support programmes at both the HIV/T2D clinics (n=5) 
"On the HIV side there are people from TAC. They used to come teach us about - like the treatment that we 
are using and the things that we should know." 
                                                        -Participant P2, female, HIV treatment: 16years, T2D treatment: 6years 
 
"We involve every stakeholder here because we have the occupational therapist, we have the 
physiotherapist, we have the health promoter, we have the social worker, so we involve all (of them) ...we 
are also trying to involve the community based carers (community health workers)" 
                                                                                                                                                  -Participant H5 
 
"We do receive some type of counselling and they (clinical staff at the T2D clinic) make sure that you 
understand the fact that now your life is going to change." 
                                                          -Participant P5, male, HIV treatment: 6 years, T2D treatment: 15years 
WEAKNESSES 
¤
Need for further information and counselling at HIV/T2D clinics (n=4) 
"For me, it is this family planning thing that, they must maybe explain in detail. You must have this kind of 
CD4 count and you must follow this procedure in order for you (to have children)...As far as I’m 
concerned, in an African culture, the woman that is married she must give birth because that is a 
continuation of the surname."          –Participant P8, male, HIV treatment: 12 years, T2D treatment: 3years 
 
“There is a supporting group… the problem is ...I don’t know how to put this…like the elders and the 
youngsters, there’s a different scenario, because the elders is so much more stereotyped about certain 
things.” - Participant P10, male, HIV treatment: 6 months, diabetes treatment (Type I and II):23 years 
 
“So, you get to the clinic and they don’t understand why your sugar levels are up. You try to explain to 
them and they don’t understand - all they tell you is that you have to try and keep it below….” 
                                                       –  Participant P6, female, HIV treatment: 9 years, T2D treatment: 6years  
 
§¤
Lack of consistent support programmes at theT2D clinic as compared to the HIV clinic (n=3) 
"(At the general clinic), the psychiatrist comes once a week or once every two weeks for a few hours. So 
the Sister has to select who sees the psychiatrist."                                                       -Participant H1, doctor 
 
"The only support we get is from soup kitchens. They come once a week but sometimes there's - they don't 
come next week and I don't understand why. And then they appear in the other week that's what we're told." 
                                                      - Participant P1, female , HIV treatment:8 years, T2D treatment: 12years                                     
 
¤
Lack of feedback on patients' clinic-related suggestions at T2D clinic (n=1) 
"As a (patient), if you are not happy just write it down; there’s a paper and a pen there. But now we don’t 
know when change will happen. Or maybe it’s the Head of the diabetic side, did he get our complaints?” 
                 - Participant P10, male, HIV treatment: 6 months, diabetes treatment (Type I and II):23 years 
§





The health services at both clinics had taken the initiative of making a suggestion box 
available in order to try to be more responsive to patient complaints and queries. The 
facility manager at the diabetes clinic was also open to meeting patients: 
“We have the manager’s office that is open to everyone. Should the person be not 
satisfied, he or she needs something to be done now, we send them to the manager's 
office” – Participant H5, CNP    
These opportunities could be considered as mechanisms of support but one patient 
viewed suggestion boxes as ineffective due to lack of feedback.  
2.4. Socio-economic resources 
 
Some patients were unable to meet their daily needs for HIV/T2D management because 
of their low socio-economic status. Three patients were in full time employment and were 
financially self -sufficient. However, two relied on a disability and old grant, 
respectively; with the rest dependent on family members for survival. Adherence to 
dietary recommendations was expressed as a major problem especially if the family had 
to share the same food:  
“You see, I (get paid) end of the month. I (get) the money; I buy the stuff I’m supposed to 
be eating. I’m not eating alone that stuff. In the middle of the month that food’s finished, 
and also the money is finished.”- Participant P7, male 
 
A doctor called for the revision of the eligibility criteria for the disability grant as 
qualification was easier for people who had physical disabilities as opposed to non-
physical disability. Two other health workers and support groups supported the idea as 
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they viewed provision of disability grants to all patients with chronic conditions would 
help patients adhere to a healthy diet: 
 TAC wrote a letter to our government and we signed in support...The proposal was for 
everyone who is unemployed and HIV positive, to get a grant - maybe a payment of a R1 
000 from Government every month." - Participant H6, CNP. 
 
However, one health worker disagreed: 
"I don’t think it’s necessary to provide them with any extra funding or anything like that 
to eat healthier, because there is food: fruit and vegetables are available and cutting 
sugar- that doesn’t cost a lot of money."-Participant H2, doctor. 
 
Two patients pointed out that food gardens could be a means of food security yet two 
other patients perceived this as impossible due to lack of space and the input required in 
producing food. 
“It's because at the place I’m staying (informal settlement) there are not a lot of yards so 
that we can have vegetable planting.” – Participant P7, male 
 
Theme 3: Access and utilisation of health services 
All participants reported that access to and utilisation of HIV/T2D health care services 
was shaped by how patients encountered administrative and consultative procedures with 
health workers; including dispensation of medication at the pharmacy, the presence and 
absence of support services at the health facility and patients’ socioeconomic status. Both 
health workers and patients were happy with the provision of health education, but 
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patients would have loved to have comprehensive clinic visits. Such aspects included 
health workers addressing other health concerns besides HIV/T2D such as minor 
illnesses and mental health; increasing pharmacy staff and balancing the number of health 
workers attending to patients during clinical staff lunch break. Three health workers and 
one patient suggested that the national government addresses health worker shortages so 
that waiting periods are shortened:  
"And the staff is too little. So I know that our managers and Government are aware of 
that." - Participant H6, CNP 
 
One patient appreciated home visits by community health workers (CHWs) to deliver 
medication to the elderly; yet another suggested having mobile clinics for T2D with 
referrals to the PHC for complicated cases. The absence of a computer system 
complicated HIV/T2D management because health workers did not have a holistic 
picture of patient data such as the illnesses that a patient had; and the history of the 
patient. One patient noted that sometimes results for annual tests were not communicated. 
Doctors also felt incapacitated to manage effectively HIV/T2D as each condition was 
treated separately, since clinical guidelines (PC101 guidelines) where separate; and 
patients had separate files and prescriptions for the two clinics.  
 
Hence, the need of a computer system that is accessible to health workers and integrated 
clinical guidelines to manage HIV/T2D were suggested: 
"The only way we can integrate that is if you have a computer system. So if I have a 
computer here, can you access reports from Ubuntu so that I can see what their CD4 
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count is, what was done last time and so on at least...We got guidelines for diabetes and 
there are guidelines for HIV, but there is no integrated guidelines. So how do you 
question management of HIV and diabetes if there is no unique guideline for that? Or 
HIV, diabetes and MDR when there is no specific guidelines for it?" - Participant H1, 
doctor 
Doctors also suggested that to promote continuity of care a system could be devised 
where patients are assigned to one or two doctors or CNPs. Further training was seen as 
ideal especially for mentoring junior doctors not to over prescribe. Health workers were 
of the opinion that generally, patients were adequately compliant in terms of medication, 
but not with diet. They also complained that patients did not attend the clinic at the 
correct times: 
"Every person who arrives at the clinic for help will be seen... (but if) it is quarter to four 
and the patient told the receptionist that they came for an HIV test, we have to leave at 
four o'clock. So we don't have enough time for the results" - Participant H4, HIV 
counsellor 
Theme 4: Health Outcomes 
Despite the health outcomes experienced by patients (Table 9), all patients maintained 
that they were managing their health adequately.  
Table 9: Health Outcomes 
Final health outcomes 
HIV related 
Permanent small body (n=1)
T2D related 
Renal failure (n=1) Chronic Obstructive Pulmonary Disease (COPD) (n=1) Hypertension (n=1) 
88 
 
HIV and T2D related 
Frustration/anger (n=1) 
 
Chronic renal failure; Cardiovascular disease; Dementia; Psychosis; Retinitis pigmentosa (loss of 
vision); Hypertension 
Intermediate health outcomes 
 
HIV related 





Uncontrolled blood sugar levels (n=5) Uncontrolled blood pressure (n=1) Blurred vision (n=3) 
Temporary disability ( n=1) Overweight (n=2) 
 
HIV and T2D related 
Dizziness ( n=3) Depression (n=1)  Hospitalisation (n=4) Fits 

Self-reported experiences by patient participants 

Doctor's diagnoses recalled from consultations at HIV/T2D clinics 
 
From the patient interviews, it was possible to assess the physical and mental functioning 
of patients as good, average or poor and give an overview of how the HIV/T2D patients 
in this study appeared to manage their health (Table 10). Improvements were noted in 
present day physical and mental functioning of both HIV/T2D patients.  
 
Table 10: Self- reported physical and mental functioning by HIV/T2D patients 
                     Physical functioning                       Mental functioning 





















Good 2 9 2 8 2 7 3 6 
Average 3 - 3 2 3 3 3 4 
Bad - - 1 - 2 - 2 - 
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Discussion 
The study confirms that there is no integration of care for chronic conditions which is in 
contrast with the ICDM and also still misaligned with the call to have integrated care for 
CDs and NCDs. Service delivery as a building block of the health system, must be 
responsive to the needs of the population [1]. However, patients in this study still 
experienced parallel health services for chronic conditions. In this study, patient 
participants identified themselves to fulfill many of the tasks of the CCM [29] which 
included clinic attendance, taking medication, learning about the conditions and self-
management behaviours. A patient’s capacity to engage in these tasks determines 
whether the work is perceived as manageable or not. All the patients interviewed in this 
study, noted that T2D management was more difficult than HIV care. This may be 
attributed to the different clinical presentations that T2D may have [34]. However, in 
South Africa, lived experiences of women who self-reported previous diagnosis of T2D 
and were also affected by HIV, illustrate the subjective nature of managing of these co- 
morbid conditions as HIV management was seen to be worse than T2D management 
[21]; which was not the case among patient participants in this study. 
Respondents in this study identified a number of barriers to achieving these tasks. These 
included a lack of financial resources to meet dietary requirements, pressure from family 
members not to follow healthy lifestyles and personal attitudes and beliefs. Although 
difficult to achieve, having control over food options and discussing nutrition with 
spouses were identified as some of the promoting factors for dietary adherence [35]. In 
addition to these factors, other challenges in optimal  diabetes self-management include 
knowledge about diabetes and patients’ adherence to treatment [36]. However, these 
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latter tasks did not appear to complicate self-care for patients in this study as depicted in 
the model. Taking medication was only seen to be difficult at point of diagnosis but 
patients were at the time of data collection, well-adjusted and had normalised this task 
into daily routine [37]. Patients valued health education on self-management. Literature 
gives the benefits of education such as  reduction of  health costs and improvement in 
general health outcomes [38] especially among literate patients [39]. 
One of the patients noted that the inclusion of all adult patients in T2D support groups at 
PHC level repelled young-adult patients’ involvement in health education activities. This 
characteristic of the current approach to chronic care in Cape Town where patients needs 
are not fully addressed may translate the same effects of anxiety and frustration of 
patients in managing their chronic conditions[40]. Reorganisation of support groups  to 
be age-specific may be done; and success stories in managing chronic conditions may be 
experienced as in the case of other settings that have homogenous support groups [41].  
Apart from face to face support groups, different forms of support groups may yield 
different results.  Mobile telephone peer support groups have reminded T2D patients on 
self-management where although in one study they did not manage to improve blood 
sugar and pressure levels [42] in another study, blood pressure was controlled [43]. 
Long waiting periods and health worker shortages were the most frustrating issues raised 
by participants at the T2D clinic. These have been identified as barriers in seeking health 
services elsewhere in South Africa [44, 45]. In contrast, HIV waiting periods are shorter 
mainly because of the ARV adherence club system; which avoids overcrowding and 
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reduces waiting times at the health facility [46] . Further innovations of organisation and 
management of chronic care have been suggested to retain patients in care such as 
workplace programmes for employed patients[47] which can also be applied to alleviate 
long waiting periods at the health facility particularly for T2D management. 
 
Patient-health worker power divide was evident: it was perceived that health workers 
taking breaks in-between work left patients unattended. While regulations stipulate on the 
need of a one  hour  meal interval after working continuously for five hours  [48] a 
functional system of rotation so that there is a balance between health workers on lunch 
break and those attending to patients was seen ideal by patients.  Health workers 
perceived suggestion boxes to be a mechanism of demonstrating patient power since 
patients could use of the suggestion boxes to post compliments and queries. However, 
patients noted that they did not get feedback making this platform ineffective for 
communication. Health worker-patient relationship has to be reciprocal such that patients 
have client power towards health providers and health workers have an obligation to 
provide service to the people [49].  
 
A multi-sectoral response to public health needs was illustrated by support services from 
the national and local government such as disability grants and provision of food supplies 
for specialised group of patients.  However, though the intention was to address 
socioeconomic challenges faced by the patients, these short-term benefits; which become 
unsustainable. While non-governmental organisations (NGOs) could be tapped as 
resources for community food gardens thus ensuring food security, challenges in long-
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term funding pose as a threat in such a development effort  [50]. Stigma was still evident 
in the community and various interventions have been suggested to diffuse HIV stigma 
which range from information based, skills building, counselling to contacting the 
affected people [51]. 
 
The role of community health workers (CHWs) in delivering home based services and 
mobile clinics was also valued; which has also been valued by other groups of patients 
such as HIV and  TB sufferers[52].  However, rolling out of the service to all chronic 
conditions (in this case HIV and T2D) could be limited by the resources needed in 
redesigning health services which are already a challenge in the Western Cape [53] and 
the complex nature of managing T2D that may require consultation with specialists. 
 
Information systems are also necessary building blocks of health systems. Weaknesses in 
administration and consultation procedures where patient had separate files for the two 
clinics, an inefficient T2D appointment system and incomplete data indicated a need for 
an integrated system such as a computer network to consolidate patient data. This has 
been recommended in the literature [54, 55]. Also though the ICDM is guided by the 
PC101 clinical guidelines, treating a patient by referring to one disease at a time and not 
understanding all the diseases a patient has may trigger unpleasant side effects which 
may come with living with multi-morbidity [13, 56-58] and using consolidated guidelines 
may be helpful. Continuity of care was raised as a strategy to improve HIV/T2D 
management and it has been associated with improved quality of care for chronic patients 
[59]. However, retention of health workers may pose as a challenge[60]. The gains 
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anticipated in continual professional development by health workers in this setting are 
noted in literature such as trainings offered within and outside the health facility which 
promote participant active participation [61]. 
Limitations  
 
 Due to resource and time constraints for this mini-thesis, the sample for this study was 
limited to 10 patients and 6 healthcare workers in one setting. This did not enable the 
researcher to explore fully all the different dimensions of the CCM model and it remains 
uncertain as to whether data saturation was achieved: it is possible that more interviews 
could have yielded further issues of relevance, a greater breadth of information and 
deeper insight on this topic. Social desirability bias could have resulted in patients 
offering the researcher a more positive picture of their situation than is really the case. 
The researcher not being a South African and not being conversant in the local language 




HIV/T2D services require better integration as the current organisation and management 
is cumbersome to both health workers and patients. In the short term, education material 
can be made available in clinics for patients which includes information on HIV, T2D 
and other chronic conditions and how best to manage these in their singularity and 
plurality. In addition, the availability of consolidated guidelines may be helpful for PHC 
facilities to have the capacity to manage co-morbidity. However, this may not be an easy 
task as health workers may need further training to enlarge their roles.  In the long term, a 
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complete re-organisation of PHC centres may be required were "separate clinics" are 
phased out and an ideal clinic in which chronic patients may have a single consultation 
for all their morbidities. This may also assist in addressing the problem of waiting 
periods. 
 
The CCM was largely an effective model of understanding patients lived experiences of 
morbidity and it brought out the variations in what may be constituted patient workload 
and patient capacity in the South African context. In this regard, incorporating its 
elements with the ICDM may provide a better approach of chronic patients managing 
their health in their home environment and their utilisation of health services. However, 
the lack of data of country examples of integrated chronic care health services of CDs 
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Appendix 1: Information Sheet and informed consent form for 
HIV/T2D patients on workload/capacity issues and their inter-
relationships as associated with multiple morbidities 
 
Strengthening Health Systems for Chronic Care: Intersection of Communicable and Non-
communicable Diseases Services in South Africa 
 
Title of study: A qualitative study on the experiences and perspectives of public sector 
patients in Cape Town in managing the workload of demands of HIV and type 2 diabetes 
co-morbidity 
 




In South Africa, more people are now living with multi morbidities which are two or 
more chronic health conditions such as HIV, TB, hypertension and type 2 diabetes (T2D). 
I am inviting you to take part in a study exploring the patient  and health provider 
perspectives related to the tasks and responsibilities which comes with HIV and type 2 
diabetes (T2D) co-morbidity and how this impacts on the patient’s capacity to effectively 
manage the condition. This study is being conducted by researchers at the Chronic 
Disease Institute of Africa and University of Cape Town. 
 
HIV and T2D co-morbidity are the selected two health conditions because more people 
are living with HIV and T2D and the heavy tasks and responsibilities needed to manage 
HIV and T2D.  HIV is a virus passed from one infected person to another through body 
fluids which needs continual treatment to live longer. Type 2 diabetes (T2D) is a chronic 
disease caused by a person not producing enough insulin, a hormone which controls the 
amount of sugar in the blood.  
 
Individual interviews will be done with a total of 10 people who are both HIV and T2D 
patients.  We would really appreciate if you could be part of these interviews so that we 
can know more on how improvements can be made in handling these two health 
conditions.  
 
Your participation in individual interviews will be face-to-face with the researcher and 
will take one hour approximately; but may extend over an hour if there are still more 
issues to discuss. The interview will be in a private room in the clinic for confidentiality. 
The interview will be audio-taped and stored on the researcher's computer. You will not 
in any way be forced to be part of the interview and you will be able to stop the interview 
at any time without having to give a reason. 
 
Once the study is complete the recording will be deleted. Your name will not be used in 
any of the reports written up about this research. After taking part in the study, you will 
receive a food voucher as a token of appreciation for agreeing to help us in this study.  
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If you have any concerns about your rights or welfare as a participant in this study please 
contact the Faculty of Health Sciences Human Research Ethics committee address: 
Faculty of Health Sciences Human Research Ethics Committee (HREC). Room 52, Old 
Main Building, Groote Schuur Hospital, Observatory 7925. Tel: +27 21 406 6338, 
Fax:+27 21 406 6411. Alternatively, please feel free to contact either one of the 
supervisors to this study:  
Researcher: Rangarirai Matima 072 492 5562  
Supervisors: Dr Tolullah Oni, 021 650 1299 
Dr Katherine Murphy, 021 406 6820 
 
Consent Form   
 
 
By signing this document: 
 
 
I confirm that I have read the above information and understand it. 
 
I confirm that I have had an opportunity to ask questions and I am satisfied with the 
answers and explanations that have been given to me. 
 
I give my permission for the researchers to use the information I give in the interview for 
the purposes of improving HIV and T2D management;  and for the purposes of academic 
publication. 
 
I understand that my participation in this discussion is voluntary and I am free to 
withdraw at any time without having to give a reason. 
 
 
I agree to take part in this research study. 
 

















Appendix 2: Information Sheet and informed consent form for 
healthcare providers on workload/capacity issues and their inter-
relationships as associated with multiple morbidities 
 
Strengthening Health Systems for Chronic Care: Intersection of Communicable and Non-
communicable Diseases Services in South Africa 
Title of study: A qualitative study on the experiences and perspectives of public sector 








In South Africa, more people are now living with multi morbidities which are two or 
more chronic health conditions such as HIV, TB, hypertension and type 2 diabetes (T2D). 
I am inviting you to take part in a study exploring the patient  and health provider 
perspectives related to the tasks and responsibilities which comes with HIV and type 2 
diabetes (T2D) co-morbidity and how this impacts on the patient’s capacity to effectively 
manage the condition. This study is being conducted by researchers at the Chronic 
Disease Institute of Africa and University of Cape Town. 
 
HIV and T2D co-morbidity are the selected two health conditions because more people 
are living with HIV and T2D and the heavy tasks and responsibilities needed to manage 
HIV and T2D.  HIV is a virus passed from one infected person to another through body 
fluids which needs continual treatment to live longer. Type 2 diabetes (T2D) is a chronic 
disease caused by a person not producing enough insulin, a hormone which controls the 
amount of sugar in the blood.  
 
Individual interviews will be done with a total of 6 people who are healthcare workers 
who work with adult chronic patients.  We would really appreciate if you could be part of 
these interviews so that we can know more on how improvements can be made in 
handling these two health conditions.  
 
Your participation in individual interviews will be face-to-face with the researcher and 
will take one hour approximately; but may extend over an hour if there are still more 
issues to discuss. The interview will be in a private room in the clinic for confidentiality. 
The interview will be audio-taped and stored on the researcher's computer. You will not 
in any way be forced to be part of the interview and you will be able to stop the interview 
at any time without having to give a reason. 
 
Once the study is complete the recording will be deleted. Your name will not be used in 
any of the reports written up about this research..  
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If you have any concerns about your rights or welfare as a participant in this study please 
contact the Faculty of Health Sciences Human Research Ethics committee address: 
Faculty of Health Sciences Human Research Ethics Committee (HREC). Room 52, Old 
Main Building, Groote Schuur Hospital, Observatory 7925. Tel: +27 21 406 6338, 
Fax:+27 21 406 6411. Alternatively, please feel free to contact either one of the 
supervisors to this study:  
Researcher: Rangarirai Matima 072 492 5562  
Supervisors: Dr Tolullah Oni, 021 650 1299 
Dr Katherine Murphy, 021 406 6820 
 
Consent Form   
 
 
By signing this document: 
 
 
I confirm that I have read the above information and understand it. 
 
I confirm that I have had an opportunity to ask questions and I am satisfied with the 
answers and explanations that have been given to me. 
 
I give my permission for the researchers to use the information I give in the interview for 
the purposes of improving HIV and T2D management; and for the purposes of academic 
publication. 
 
I understand that my participation in this discussion is voluntary and I am free to 
withdraw at any time without having to give a reason. 
 
 
I agree to take part in this research study. 
 















Appendix 3: Interview schedule for patients 
 
A.  Please tell me a story of what happens on a day you visit the clinic - from the time 
you wake up until you leave the clinic.  
B. What do you like best; and how can things be done differently for you to be satisfied 
during your clinic visit?  
 
C. May you tell me how you are managing/handling your health at home.  
D. What can you think of, that can make it less difficult/easier for you to manage your 
health? 
E. How well do you think you are doing in managing your health along with the other 
everyday responsibilities you have? What would you say is working well for you? And 
what is not working so well? Please explain and give your reasons.  
F. If you have had any side effects to the medication, can you explain one of your 
experiences? What may have happened and what helped you to pull through? OR If you 
have had no side effects to the medication, can you explain what may have helped you to 
stay healthy? 
G. Since having these health problems what would you say to any other person who also 
has chronic conditions?  
H. Is there anything else you would like to tell me about your health and how you are 



















Appendix 4: Interview schedule for health providers 
 
A. May you please explain to me what usually happens when a patient with HIV/ T2D 
comes for a clinic visit; from the moment he or she arrives at the facility until he or she 
leaves the facility?  
 
B. How would you describe your specific role regarding the care of these patients? 
 
C. What do you like best about your current clinical practices for patients with HIV/T2D; 
and how can things be done differently?  
D. In what ways do you think HIV and T2D have impacted on patient’s quality of life? 
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Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and 
chiral symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108. 
 
Complete book, authored 
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Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of 
common illness. 3rd ed. Oxford: Blackwell Science; 1998. 
 
Online document 
Doe J. Title of subordinate document. In: The dictionary of substances and their effects. 
Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate 
document. Accessed 15 Jan 1999. 
 
Online database 
Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. 
http://www.healthwise.org. Accessed 21 Sept 1998. 
 
Supplementary material/private homepage 
Doe J. Title of supplementary material. 2000. http://www.privatehomepage.com. 
Accessed 22 Feb 2000. 
 
University site 




Doe, J: Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 
12 Nov 1999. 
 
Organization site 
ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20 
Feb 2007. 
 
Dataset with persistent identifier 
Zheng L-Y, Guo X-S, He B, Sun L-J, Peng Y, Dong S-S, et al. Genome data from sweet 
and grain sorghum (Sorghum bicolor). GigaScience Database. 2011. 
http://dx.doi.org/10.5524/100012. 
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When preparing figures, please follow the formatting instructions below. 
    Figures should be provided as separate files, not embedded in the main manuscript file. 
    Each figure of a manuscript should be submitted as a single file that fits on a single 
page in portrait format. 
    Tables should NOT be submitted as figures but should be included in the main 
manuscript file. 
    Multi-panel figures (those with parts a, b, c, d etc.) should be submitted as a single 
composite file that contains all parts of the figure. 
    Figures should be numbered in the order they are first mentioned in the text, and 
uploaded in this order. 
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    Figures should be uploaded in the correct orientation. 
    Figure titles (max 15 words) and legends (max 300 words) should be provided in the 
main manuscript, not in the graphic file. 
    Figure keys should be incorporated into the graphic, not into the legend of the figure. 
    Each figure should be closely cropped to minimize the amount of white space 
surrounding the illustration. Cropping figures improves accuracy when placing the figure 
in combination with other elements when the accepted manuscript is prepared for 
publication on our site. For more information on individual figure file formats, see our 
detailed instructions. 
    Individual figure files should not exceed 10 MB. If a suitable format is chosen, this file 
size is adequate for extremely high quality figures. 
    Please note that it is the responsibility of the author(s) to obtain permission from the 
copyright holder to reproduce figures (or tables) that have previously been published 
elsewhere. In order for all figures to be open access, authors must have permission from 
the rights holder if they wish to include images that have been published elsewhere in 
non open access journals. Permission should be indicated in the figure legend, and the 
original source included in the reference list. 
 
Figure file types 
 
We accept the following file formats for figures: 
    EPS (suitable for diagrams and/or images) 
    PDF (suitable for diagrams and/or images) 
    Microsoft Word (suitable for diagrams and/or images, figures must be a single page) 
    PowerPoint (suitable for diagrams and/or images, figures must be a single page) 
    TIFF (suitable for images) 
    JPEG (suitable for photographic images, less suitable for graphical images) 
    PNG (suitable for images) 
    BMP (suitable for images) 
    CDX (ChemDraw - suitable for molecular structures) 
 
For information and suggestions of suitable file formats for specific figure types, please 
see our author academy. 
Figure size and resolution 
 
Figures are resized during publication of the final full text and PDF versions to conform 
to the BioMed Central standard dimensions, which are detailed below. 
 
Figures on the web: 
    width of 600 pixels (standard), 1200 pixels (high resolution). 
 
Figures in the final PDF version: 
    width of 85 mm for half page width figure 
    width of 170 mm for full page width figure 
    maximum height of 225 mm for figure and legend 




Figures should be designed such that all information, including text, is legible at these 
dimensions. All lines should be wider than 0.25 pt when constrained to standard figure 
widths. All fonts must be embedded. 
 
Figure file compression 
     Vector figures should if possible be submitted as PDF files, which are usually more 
compact than EPS files. 
    TIFF files should be saved with LZW compression, which is lossless (decreases file 
size without decreasing quality) in order to minimize upload time. 
    JPEG files should be saved at maximum quality. 
    Conversion of images between file types (especially lossy formats such as JPEG) 
should be kept to a minimum to avoid degradation of quality. 
 
If you have any questions or are experiencing a problem with figures, please contact the 
customer service team at info@biomedcentral.com. 
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Preparing tables 
 
When preparing tables, please follow the formatting instructions below. 
    Tables should be numbered and cited in the text in sequence using Arabic numerals 
(i.e. Table 1, Table 2 etc.). 
    Tables less than one A4 or Letter page in length can be placed in the appropriate 
location within the manuscript. 
    Tables larger than one A4 or Letter page in length can be placed at the end of the 
document text file. Please cite and indicate where the table should appear at the relevant 
location in the text file so that the table can be added in the correct place during 
production. 
    Larger datasets, or tables too wide for A4 or Letter landscape page can be uploaded as 
additional files. Please see [below] for more information. 
    Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls 
) or comma separated values (.csv). Please use the standard file extensions. 
    Table titles (max 15 words) should be included above the table, and legends (max 300 
words) should be included underneath the table. 
    Tables should not be embedded as figures or spreadsheet files, but should be formatted 
using ‘Table object’ function in your word processing program. 
    Color and shading may not be used. Parts of the table can be highlighted using 
superscript, numbering, lettering, symbols or bold text, the meaning of which should be 
explained in a table legend. 
    Commas should not be used to indicate numerical values. 
 
If you have any questions or are experiencing a problem with tables, please contact the 
customer service team at info@biomedcentral.com. 
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Preparing additional files 
As the length and quantity of data is not restricted for many article types, authors can 
provide datasets, tables, movies, or other information as additional files. 
All Additional files will be published along with the accepted article. Do not include files 
such as patient consent forms, certificates of language editing, or revised versions of the 
main manuscript document with tracked changes. Such files, if requested, should be sent 
by email to the journal’s editorial email address, quoting the manuscript reference 
number. Please do not send patient consent forms unless requested. 
Results that would otherwise be indicated as "data not shown" should be included as 
additional files. Since many web links and URLs rapidly become broken, BioMed 
Central requires that supporting data are included as additional files, or deposited in a 
recognized repository. Please do not link to data on a personal/departmental website. Do 
not include any individual participant details. The maximum file size for additional files 
is 20 MB each, and files will be virus-scanned on submission. Each additional file should 
be cited in sequence within the main body of text. 
For further guidance on how to use Additional files or recommendations on how to 
present particular types of data or information, please see How to use additional files. 
